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Iridovirus is a pathogen causing serious systemic diseases among feral, 
cultured and ornamental fish. Our lab aims to explore iridovirus infection mechanism 
and anti-iridovirus drug discovery. A knockdown platform has been built up for an 
effective knockdown of certain genes from SGIV. With phenotype screening a 
functional important SGIV encoded protein - ORF018R was successfully identified. 
Immunofluorescence staining showed that ORF018R expressed in high abundance in 
SGIV-infected cells. Knockdown of ORF018R expression resulted in reduction of 
expression of viral late genes, distortion of viral particle assembly and inhibition of 
SGIV infection in grouper embryonic cells. Immunoblot and 2DE-MS showed five 
enhanced phosphorylated proteins including three viral proteins: ORF049L 
(dUTPase), ORF075R and ORF086R; two host proteins: subunit 12 of eukaryotic 
translation factor 3 (eIF3) and natural killer enhancing factor (NKEF). Furthermore, 
LTQ-Orbitrap experiment identified that the peptide - ORF049L (aa142-152) was 
phosphorylated by ORF018R knockdown. Moreover, One SGIV encoded kinase-
ORF039L was identified and another viral protein ORF075R could be phosphorylated 
by ORF039L in vitro. Thus ORF018R was probably a kinase inhibitory protein in 
SGIV infected cells. EGFP fusion viral proteins were expressed in host cell line to 
screen virus-host interaction. Only ORF082L-EGFP showed special localization. Pull 
down assay with GST-ORF082L revealed that this protein probably had two binding 
partners, namely enolase and actin. Based on this study, the mechanism of SGIV 
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1.1 Overview of the DNA virus Family Iridoviridae 
1.1.1 Classification of the DNA virus Family Iridoviridae  
Viruses are microorganisms that can only reproduce by invading and taking 
over host cells due to their lack of own cellular machinery for reproduction. The term 
"virus", which comes from the Latin virus, means poisons and other noxious things 
and usually refers to those particles that infect eukaryotes including both multicellular 
and single-cell organisms. Typically, these particles carry a small amount of nucleic 
acid (either DNA or RNA) surrounded by some forms of protective coat consisting of 
proteins, or proteins and lipids (Knipe and Howley, 2001). The origin of modern 
viruses is not entirely clear. Currently there are two main hypotheses: small viruses 
with only a few genes may be runaway stretches of nucleic acid originating from the 
genome of a living organism; Viruses with larger genome may have once been small 
cells which parasitised larger host cells. Over time, genes that are not required by their 
parasitic lifestyle would have been lost in streamlining process known as retrograde-
evolution or reverse-evolution (Prescott, 1993; http://en.wikipedia.org/wiki/Virus). 
 
Virus taxonomy can be defined as the arrangement of viruses into related 
clusters, the identification of the extent of relatedness within and among these clusters, 
and their nomenclatures. The main principles in devising taxonomy for viruses are 
stability, utility, acceptability, flexibility (Mayo and Pringle, 1998). Based on this 
criterion, the general structure is as follows: Order (-virales), Family (-viridae), 
Subfamily (-virinae), Genus (-virus), Species (-virus). Currently viruses can be 
classified as DNA viruses and RNA viruses based on their genome compositions. 

































Figure 1.1 Current state of DNA viruses taxonomy 
 
Genera are listed in boxes below the appropriate family names. Families which make 
up orders are boxed within a solid line. Divisions of families into sub-families are 
indicated by horizontal dashed lines. Genera in untitled grey boxes are those not yet 
assigned to families. Where taxa, names or classifications have been decided since the 











Iridoviruses are large, icosahedral viruses with a linear, double-stranded DNA 
genome (Chinchar et al., 2005). As one of the 17 families in dsDNA virus, the family 
Iridoviridae has been classified into four genuses – Iridovirus, Chloriridovirus, 
Ranavirus and Lymphocystivirus by 2005 (van Regenmortel et al., 2000). But 
Williams and Chinchar have added a new genus - Megalocytivirus (Chinchar et al., 
2005). Hosts of the former two genera come from invertebrates such as flies, 
silkworms, and mosquitoes. Nomenclature of invertebrate isolates is based on the host 
species and is given a type number on the basis of the sequence of discovery 
following a recommended interim system (Tinsley and Kelly, 1970). The small 
iridoviruses, 120-140 nm in diameter, are classified into genus iridovirus. The large 
iridoviruses, about 180 nm in diameter, are under the genus Chloriridovirus whose 
isolates are derived from mosquitoes. The latter two genera-Ranavirus and 
Lymphocystivirus only infect cold blooded animals including fish, amphibians, and 
reptiles. There are many isolates from fish and frogs, such as frog virus 3 (FV3), the 
type virus for the genus Ranavirus and the lymphocystis disease virus type 1 (LCDV-
1), the type virus of the genus Lymphocystivirus. The new genus-Megalocytivirus 
only infects marine fish in South East Asia and involves multiple internal organs. 
However, several isolates have not been characterized to a sufficient level to be 
assigned to any genus. Several species under the family Iridoviridae are listed at Table 












Table 1.1 Current classification of the Family Iridoviridae 
 
Iridovirus Tipula paluosa IV 
 
Diverse invertebrate taxa 
(mostly insects) Sericesthis pruinosa IV 
  Chilo suppessalis IV 
Chloriridovirus Diptera (mosquitoes) Acdes taeniorhynchus IV 
  Acedes cantans IV 
Ranavirus Frog virus 3 
 
Amphibian and teleost 
families Frog virus 1, 2, 5-24 
  Singapore grouper iridovirus 
  Ambystoma tigrinum virus 
  Tiger frog virus 
Lymphocystiviru Teleost families Lymphocystis disease virus type 1-
2  Lymphocystis disease virus type c 
  Octopus vulgaris disease virus 
Megalocytivirus Marine fish Red Sea bream iridovirus 
  Taiwan grouper iridovirus 
  Olive flounder iridovirus 
  Rock bream iridovirus 









1.1.2 Structure of the Iridoviruses 
Iridoviruses are icosahedral viruses, 120 to 300 nm in diameter. The genome 
of iridoviruses is a linear, double-stranded DNA molecule with the size is between 
100 and 210 kbp. All of iridoviral genomes are circularly permuted and terminally 
redundant. Iridoviruses have a layered structure composed of a spherical dsDNA-
protein core, surrounded in turn by a lipid bilayer and an icosahedral capsid consisting 
of copious protein subunits (Yan et al., 2000). 
 
The core of a viral particle is an electron-dense, highly hydrated part 
containing about 80% of H2O in FV3 (Cuillel et al., 1979). Previous thermodynamic 
studies verified the existence of a nucleosomal structure in Chilo iridescent virus 
(Klump et al., 1983). Ultrasonic adsorption studies show that the core is composed of 
a DNA-protein complex (Robach et al., 1983). Freeze-etching of FV3 virion reveals 
that a rod-like structure exists in the virus interior, suggesting that there is a certain 
structure among the DNA and protein components of the core (Tripier-Darcy et al., 
1984). It appears that the rod-like structure shapes a coiled filament as a bridge to 
connect the DNA-protein core with the lipid layer (Williams, 1996). The lipid bilayer 
between core polypeptides and inner capsid is approximately 4 nm thick (Cuillel et al., 
1979). It is a critical part for infectivity in the vertebrate iridoviruses (Berry et al., 
1983; Speare and Smith, 1992). The lipid content of iridovirus virion has been 
reported from 5.2% to 17% (Williams, 1996). Phospholipid is the main component of 
the total lipids. The composition of viral phospholipid is identical to the host cell in 
vertebrate iridovirus such as FV3 (Willis and Granoff, 1974), but is obviously 
different in the invertebrate iridovirus such as Chilo iridescent virus. The capsid, 
consisting of the inner and outer capsid, is an icosahedral lattice of closely packed 
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hexagonal subunits. The subunits are composed of a single polypeptide of about 50 
kDa, major capsid protein (MCP), which occupies almost half of the total viral 
proteins (Stohwasser et al., 1993). Some viruses possess an outer envelope acquired 
from budding through host cell membranes (Cuillel et al., 1979; Tripier-Darcy et al., 
1982). Fibrillar structures surrounding the outer capsid of Chilo iridescent virus have 
been reported (Yan et al., 2000). The fibrils are up to 200 nm length, while they 
appear as a fringe around the edge of the capsid in other iridoviruses (Zwillenberg and 
Wolf, 1968; Willison and Cocking, 1972).  
 
1.1.3 Previous Functional Genomic Studies of the Iridoviruses 
Currently, ten iridovirus genomes have been sequenced and compared: IIV-6 
(Jakob et al., 2001), LCDV-1 (Tidona et al., 1997), LCDV-C (Zhang et al., 2004), 
TFV (He et al., 2002), FV-3 (Tan et al., 2004), ATV (Jancovich et al., 2003), ISKNV 
(He et al., 2001), RBIV (Do et al., 2004), SGIV (Song et al., 2004) and GIV (Tsai et 
al., 2001) (Table 1.2). Some of these viruses likely comprise distinct species within 
the same genera (e.g., LCDV and LCDV-C; ATV, SGIV, and FV-3), while others 
appear to be isolates of the same viral species. Analysis of iridovirus genomes 
indicates that putative ORFs are closely packed without introns, and are generally 
nonoverlapping. Moreover, repeat regions and palindromes appear to be very 
common among iridoviruses (Jancovich et al., 2003) which might play a role in viral 
gene transcription as initiation or termination signals.  
Iridovirus genes can be classified into four categories: (i) genes directly 
involved in virus replication, (ii)genes involved in immune evasion, (iii)genes 
homologous to those seen in other iridoviruses but not homologous to other genes in 

























Ranavirus FV-3 105,903 98 55 AY548484 
 TFV 105,057 105 55 AF389451 
 ATV 106,332 96 54 AY150217 
 SGIV 140,131 162 49 AY521625 
 GIV 139,793 120 49 AY666015 
Lymphocystivirus LCDV-1 102,653 110 29 L63515 
 LCDV-C 186,247 176 27 AY380826 
Megalocytivirus ISKNV 111,362 105 55 AF371960 
 RBIV 112,080 118 53 AY532606 











Table 1.3 Core components of iridovirus genes 
Virus species and tentative species Category/ 
gene product FV-3 TFV ATV SGIV GIV LCDV-1 LCDV
-C 
IIV-6 ISKNV RBIV 
DNA/RNA Synthesis           
DNA polymerase √ √ √ √ √ √ √ √ √ √ 
RNA polymerase II, α √ √ √ √ √ √ √ √ √ √ 
RNA polymerase II, β √ √ √ √ √ √ √ √ √ √ 
RAD2 repair enzyme √ √ √ √ √ √ √  √ √ 
DNA methyltransferase √ √ √   √ √  √ √ 
Rnase III √ √ √ √ √ √ √ √ √ √ 
Helicase  √ √  √ √ √ √  √ √ 
Topoisomerase-like enzyme        √   
mRNA capping enzyme          √ 
Salvage Pathway           
Ribonucleotide reductase, α √ √ √ √ √ √ √ √   
Ribonucleotide reductase, β √ √ √ √ √ √ √ √ √ √ 
dUTPase √ √ √ √ √   √   
Thymidylate synthase  √ √    √ √   
Thymidine kinase    √ √ √  √   
Thymidylate kinase √  √    √ √  √ 
Purine nucleoside    √ √      
Immune evasion           
eIF-2α homolog Δ √ √        
β-OH steroid oxidoreductase √ √ Δ √ √ √ √    
CARD-containing protein  √  √ √ √  √    
TNF receptor    √ √ √ √    
TRAF2-like protein          √ 
Bak-like protein    √ √      
Miscellaneous           
CTD-like phosphatase    √ √  √    
Reverse transcriptase-like       √    
ATP-dependent protease √          
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Inhibitor of apoptosis        √   
PCNA √  √   √ √ √   
Major capsid protein √ √ √ √ √ √ √ √ √ √ 
Ubiquitin-like protease    √ √      
Protein phosphorylation           
Tyrosine kinase √ √ √ √ √ √ √ √ √ √ 
Serine/threonine kinase √ √ √ √ √ √ √ √ √ √ 
 
 




Compared with other members of Iridovirdae family, Singapore Grouper 
Iridovirus (SGIV) has some unique features: 1. it is the only vertebrate iridovirus 
which does not have any DNA methyltransferase based on sequence homology 
analysis. 2. it has both ubiquitin and E3 which play important roles in Ubiquitin-
Proteasome pathway.  
 
Most viral genes with homology to known cellular genes are involved in DNA 
and RNA metabolism; other known viral genes might play some roles in evading host 
immune responses (Alcami and Koszinowski, 2000). For example, ranaviruses encode 
genes with homology to a βhydroxysteroid oxidoreductase (βSOR), the α subunit 
of eukaryotic initiation factor 2 (eIF-2α), and a caspase recruitment domain CARD-
containing protein (vCOP) (Essbauer et al., 2001; Jancovich et al., 2003; Tan et al., 
2004).  
 
A total of 162 putative ORFs is assigned for SGIV and 24 of which have been 
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identified with significant homology to known cellular proteins, another 66 with 
sequence similarities with unknown proteins of Iridovirdae family or have a relative 
low homology with known proteins; The remaining 72 putative proteins have no 
significant homology in the current database (Song et al., 2004). Previously our lab 
has identified several SGIV structural proteins with different proteomics methods (1D 
SDS-PAGE MALDI TOF PMF approach; 1D SDS-PAGE MALDI-TOF MS/MS 
approach and LC-MALDI shotgun approach) (Song et al., 2004, Song et al., 2006). 
For the first two proteomics methods, the purified SGIV virions were treated with 
SDS-loading dye and resolved with 1D SDS-PAGE, the protein bands were incised 
from gel and analyzed with mass spectrometry. For PMF approach only peptide 
information was captured by MS machine and for MS/MS approach the peptides with 
high signal intensity were further analyzed and its amino acid information was further 
identified by MS. For the third method, purified virions were disrupted by sonication 
and the peptide mixtures from purified virion were separated with liquid-
chromatography. The different peptide fraction will be analyzed by MALDI-TOF 
MS/MS.    
 Sixty-one proteins were identified by three different MS approaches and 
among them seventeen proteins were identified by all MS approaches which 
suggested that these seventeen proteins are abundant structural proteins (Figure 1.2) 

















Green area represents proteins identified by MALDI TOF PMF approach; red one 
represents proteins distinguished by MALDI-TOF MS/MS approach; blue one 
represents proteins detected by LC-MALDI. Cross regions represent proteins 
designated by two or three methods. Yellow area represents proteins identified by 
MALDI TOF PMF and MALDI-TOF MS/MS approaches; cyan one represents 
proteins designated by MALDI TOF PMF and LC-MALDI approaches; purple one 
represents proteins detected by MALDI-TOF MS/MS and LC-MALDI approaches. 
There were 17 proteins identified by three approaches (Song Wen Jun, 2005). 
 
Underscored ORF represents a protein of known function 





















































































1.1.4 Replication Strategy of the Iridovirus 
Current understanding of iridovirus replication mainly comes from the study 
of FV-3 (Figure 1.3). The virus particle binds to a currently unknown cellular receptor 
(Chinchar, 2002). Following binding to host cells, enveloped virus is thought to enter 
via receptor mediated endocytosis, whereas naked virions uncoat by fusion at the 
plasma membrane. Subsequently, viral DNA cores make their way to the nucleus. 
Viral gene expression begins in the nucleus: First early viral transcripts of two classes, 
immediate early (IE) and delayed early (DE), are synthesized using input virion DNA 
as a template. Early transcripts are thought to encode regulatory proteins and key 
catalytic enzymes such as the viral DNA polymerase and the viral homologs of 
cellular RNA polymerase II. After translated in the cytoplasm, DNA polymerase 
enters the nucleus and duplicates the viral genome, representing first stage of DNA 
synthesis (Goorha, 1982). Newly synthesized viral DNA is delivered into the 
cytoplasm where viral DNA forms large concatameric structure (Goorha and Dixit, 
1984). Until now, in vertebrate iridovirus, SGIV is the only one that lacks a DNA 
methyltransferase which suggested that methylation of viral genome DNA is not an 
essential step for viral infection (Song et al., 2004). 
 
In the late infection stage, cytoplasmic viral assembly sites (AS) are found in 
the iridovirus infected host cell. It is still unknown how AS is formed. Some evidence 
suggest that late (L) viral mRNA synthesis takes place within AS and is catalyzed by 
a virus-modified or virus-encoded cellular polymerase (Tan et al., 2004). These late 
viral transcripts encode viral structural proteins which assemble virion particle. The 
packaging of viral DNA is thought to be carried out by a “headful” mechanism using 
concatameric DNA as an intermediate (Goorha and Murti, 1982). The packaged viral 
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genome is circularly permuted and terminally redundant which may have an 
evolutionary advantage. Since 10%-30% of the viral genome is effectively diploid, 
mutations within these diploids would allow the emergence of new function of viral 
proteins without disturbing the viral infection. Events in virus replication are 













Fig1.2 Iridovirus replication cycle. 
 
 








1.2 Application of Antisense Technology in Anti-Virus Research 
When a particular gene is known to be the causative agent of a certain disease, 
it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical 
analogue) that will bind to the messenger RNA (mRNA) produced by that candidate 
gene and inactivate it, effectively turning that gene "off". This synthetic nucleic acid 
is termed an "anti-sense" oligonucleotide because its base sequence is complementary 
to the gene's messenger RNA (mRNA), which is called the "sense" sequence (so that 
a sense segment of mRNA " 5'-AAGGUC-3' " would be blocked by the anti-sense 
mRNA segment "3'-UUCCAG-5' ") (http://www.gene-tools.com/). Antisense drugs 
are being explored to treat lung cancer, diabetes and diseases such as asthma and 
arthritis with an inflammatory component. Most potential therapies have not yet 
produced significant clinical results, though one antisense drug, fomivirsen (marketed 
as Vitravene), has been approved by the US Food and Drug Administration (FDA) as 
a treatment for cytomegalovirus retinitis (Margraf et al., 2001). Nowadays two 
antisense technologies are widely applied in biological research and drug discovery: 
One is RNAi technology which has recently become widely used for gene knockdown 
in vitro and in vivo (Warfield et al., 2006) and the other is morpholino technology 
which has been extensively used in developmental biology.  
 
Both of these antisense technologies have been applied in virus research and 
anti-virus drug discovery. RNAi technology was first identified as the mediator of 
posttranscriptional gene silencing (PTGS) in the nematode Caenorhabditis elegans 
(Fire et al., 1998) and subsequently numerous genes involved in RNAi were identified 
in plants, nematodes, fruit flies, and fungi which suggest an evolutionarily conserved 
mechanism (Hutvagner and Zamore, 2002). With a rapid advance in RNAi technology, 
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it was widely applied in antivirus research. Some viruses, such as Hepatitis B Virus 
(Peng et al., 2005), Herpes Simplex Virus (Muylaert and Elias, 2007) and Vaccinia 
Virus (Dave et al., 2006) were successfully inhibited with RNAi technology. However, 
it was also found that many viruses, such as West Nile virus (Geiss et al., 2005), HIV-
1 (Bennasser et al., 2005), and Adenovirus (Lu and Cullen, 2004) coevolved with 
their host and had developed different mechanisms to escape from RNAi-based 
immune response (Li and Ding, 2006).  
 
Morpholino, as an artificial oligonucleotide, was first applied in zebrafish 
developmental biology (Nasevicius and Ekker, 2000), and recently was widely 
applied in antivirus research (Stein et al., 2001). It has been proven that morpholino 
could effectively inhibit the proliferation and growth of both RNA virus and DNA 
virus, such as HCV (McCaffrey et al., 2003), coronavirus (Neuman et al., 2005), 
Equine arteritis virus (Van den Born et al., 2005), Ebola virus (Enterlein et al., 2006) 
and Frog Virus 3 (Sample et al., 2007).  
 
Each of these two popular anti-sense technologies has its own advantages and 
disadvantages. Unlike the morpholinos, siRNA is a type of natural occurring 
nucleotides and acts as a part of immune system, and it is possible to in vivo 
synthesize siRNAs continuously. On the other hand, siRNA plays complex roles in 
vivo and it is very hard to clarify and eliminate its side effects which sometimes could 
be lethal. On the contrary, morpholino, as an artificial chemical compound with no 
charge, is stable and plays a simple role in vivo. Its side effects are relatively easier to 
be clarified and eliminated. Thus morpholino might be a better antiviral drug 
candidate (http://www.gene-tools.com).   
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1.3 Proteomics Approach for Function Study of Proteins 
1.3.1 What is Proteomics (http://en.wikipedia.org/wiki/Proteomics) 
Proteomics is the large-scale study of proteins, particularly their structures and 
functions. The term "proteomics" was created to make an analogy with genomics, the 
study of the genes. The word "proteome" is a portmanteau (a word combined with two 
words) of "protein" and "genome". The proteome of an organism is the set of proteins 
produced by it during its life, and its genome is its set of genes. Proteomics is often 
regarded as the next step in the study of biological systems, after genomics. It is much 
more complex than genomics, because while an organism's genome is constant, a 
proteome differs from cell to cell. Even within a single cell it varies with the different 
environment of this cell. This increased complexity derives from post-transcriptional 
mechanisms such as alternative splicing, protein modification (glycosylation, 
phosphorylation) and protein degradation. Proteomics is a fast developing field of 
biology that is concerned with the systematic, large-scale analysis of proteins. It is 
based on the concept of the proteome as a complete set of proteins produced by 
certain cells or organism under a defined set of conditions. Proteomics can be seen as 
a mass-screening approach to molecular biology, which aims to document the overall 
distribution of proteins in cells, to identify and characterize individual proteins 
changes, and ultimately to elucidate their functional relationships (Twyman, 2004). 
 
1.3.2 The Branches of Proteomics (Anderson and Anderson, 1998) 
(http://en.wikipedia.org/wiki/Proteomics) 
a) Protein separation 
Several Proteomics technologies rely on the ability to separate a complex 
mixture so that individual proteins are more easily processed with other techniques. 
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The general separation methods are one dimensional electrophoresis, two dimensional 
electrophoresis and many kinds of liquid chromatography, which are widely applied 
in different sample preparations for diversified aims.   
 
b) Protein identification 
The traditional methods include protein sequencing through Edman 
degradation and antibody-based assay. High-throughput identifications are based on 
mass spectrometry, common peptide mass fingerprinting on MALDI-TOF instruments, 
or De novo repeat detection MS/MS on instruments. This particular approach allows 
identifying homology proteins in different species. 
  
c) Protein quantification 
Gel-based methods are used, including differential staining of gels with 
fluorescent dyes. Gel-free methods include various tagging or chemical modification 
methods, such as isotope-coded affinity tags (ICATs), metal coded affinity tags 
(MeCATs) or combined fractional diagonal chromatography (COFRADIC) 
(Belhajjame et al., 2005) 
 
d) Protein sequence analysis 
This technology is to deal with searching databases for possible proteins or 
peptides matched by algorithms such as Mascot, PEAKS(software), OMSSA, 
SEQUEST and X!Tandem. It also reveals some information by functional assignment 





e) Interaction proteomics 
This platform is to investigate protein interactions on the atomic, molecular 
and cellular levels with yeast two-hybrid, antibody-based assay, native PAGE-MS and 
LC-MS methods. 
 
f) Protein modification 
This platform studies the modified forms of proteins. Special methods such as 
phosphoproteomics and glycoproteomics have been developed to study 
phosphorylation and glycosylation. 
 
g) Cellular proteomics 
This platform is to localize proteins and protein-protein interactions in the 
cells during key cell events. Its core techniques include X-ray tomography and optical 
fluorescence microscopy.  
 
1.3.3 Application of Proteomics in SGIV Gene Function Study 
 In this thesis we have combined the gene knockdown method with 2DE-MS to 
clarify viral gene function and to explain phenotypic changes with certain gene 
knockdown. Our result indicated that 2DE map is a good fingerprint for the cellular 
proteins. The diversified biological systems are most likely explained by certain 
protein changes (modification, splicing, upregulation, and downregulation) which will 
be identified with proteomics methods. These will be very helpful to elucidate the 
mechanisms of complex biological system. 
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1.4 Viral Infection and Phosphorylation/dephosphorylation  
1.4.1 Virus-related Phosphatases 
1.4.1.1 Virus Encoded Phosphatases 
The critical roles that phosphorylation and dephosphorylation of proteins play 
in the regulation of numerous biological phenomena have been extensively revealed 
recently. Virus infection, as one of the important biological phenomena, is also 
affected by phosphorylation and dephosphorylation events.  
 
Half a century ago, the inactivation of herpes simplex virus (HSV) by 
phosphatase enzymes in vitro has been observed, which suggested that some of the 
HSV capsid or envelop proteins might contain essential phosphorylated sites and 
dephosphorylation of such proteins probably caused their disability and loss of HSV 
infectivity (Amos, 1953). However, in the following forty years, the cellular general 
acid and alkaline phosphatases study were the main research targets because of 
technical limitation, After that, the alkaline phosphatase activity assays were fully 
developed and for virus-derived diseases diagnoses (Tanwani et al., 1978). In 1990 an 
acid phosphatase activity was detected in purified African swine fever virus, and the 
authors believed that African swine fever virus encoded an acid phosphatase (Valdeira 
et al., 1990). The first animal virus-encoded phosphatase was identified from vaccinia 
virus (Guan et al., 1991). This phosphatase was conserved in several orthopoxviruses 
and a baculovirus (Hakes et al., 1993). Some of the identified viral phosphatases were 





Table 1.4 Identified viral encoded phosphatases 
 







PP1 or PP2A 28 Regulate viral 
transcription 
Cohen and Cohen, 
1989 
VH1 Vaccinia virus 
Baculovirus 
PTPase 20 Viral 
transcription 






PTPase 27 Viral 
transcription 



















Peters et al., 2002 
 
 
1.4.1.2 Virus Regulated Phosphatases 
Besides some of viruses’ encoded phosphatases, many other viruses encode 
several regulator proteins which interacted with host encoded phosphatases to 
facilitate viral infection.  
One well studied virus related host phosphatase is protein phosphatase 2A 
(PP2A). PP2A is a typical serine/threonine-specific protein phosphatase. PP2A was 
first identified as an activator of Simian virus 40 DNA replication (Lawson et al., 
1990). It was found that PP2A was inhibited by binding with simian virus 40 small-t 
antigen (Mungre et al., 1994) and simian virus 40 large T antigen was 
dephosphorylated by PP2A (Scheidtmann et al., 1991). Recently another 
serine/threonine-specific protein phosphatase-PP1 was also found to be activated by 
DP71L, an African swine fever virus encoded protein. Its activation was involved in 
translational regulation (Rivera et al., 2007).  
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1.4.2 Virus-related Protein Kinases 
1.4.2.1 Virus Encoded Protein Kinases 
In the 1970s several investigators first found that many purified animal viruses 
such as vaccinia virus (Paoletti and Moss, 1972), frog virus 3 (Silberstein and August, 
1973), vesicular stomatitis virus (Imblum and Wagner, 1974), and avian 
myeloblastosis virus (Tsiapalis, 1977) were associated with certain protein kinases 
and phosphoproteins, although they could not determine whether these enzymes were 
host-encoded or virus-encoded. In 1978 the first virus-encoded protein kinase-pp60src 
was identified from avian sarcoma virus (Levinson et al., 1978) and in the past thirty 
years, many virus-encoded kinases were identified which involved in the whole virus 
infection processes. Some of these kinases were listed in Table 1.5: 
 
 
Table 1.5 Identified viral encoded kinases 
 



















Lin et al., 1992 






68 Anti-apoptosis Purves et al., 1987  
Benetti and Roizman, 2004 






Wu et al., 1990 





50 Virus assembly Lin and Broyles, 1994 






1.4.2.2 Host Protein Kinases Utilized by Virus 
Besides some viruses have self-encoded protein kinases, many viruses utilize 
host protein kinases to modify their own proteins. Almost every kind of highly 
conserved protein kinases were found to be utilized by certain viruses. For example, 
protein kinase A phosphorylates herpes simplex virus ICP4 serine-rich region, which 
is critical in viral replication (Xia et al., 1996); protein kinase C was required for 
respiratory syncytial virus fusion to human bronchial epithelial cells (San-Juan-
Vergara et al., 2004); casein kinase 2 is essential for Mayaro virus infection cycle 
(Barroso et al., 2002). Generally many viral proteins need to be correctly 
phosphorylated by specific host protein kinases before they serve their functions.        
 
1.4.3 Virus Infection and Phosphorylation/Dephosphorylation 
It is believed that viruses evolve from the genome of a living organism or 
small cells which parasitized larger host cells. Because viruses’ genes are not enough 
to support their own duplication, they have to replicate in host cells with the host 
transcriptional and translational machinery. Phosphorylation/dephosphorylation plays 
important roles in most all biological processes. Viruses, as parasitic organisms, have 
to evade host immune system, suppress host cells apoptosis and hijack host 
transcriptional and translational machineries for their own duplications. To survive as 
parasitic organisms, viruses have developed diversified strategies to manipulate host 
cells. One of the most effective strategies is to control phosphorylation and 
dephosphorylation which covers all aspects of virus infection processes. Disruption of 




1.5 Treatment of Viral Diseases from Protein Phosphorylation 
1.5.1 Overview of Viral Diseases 
Some of the viruses will remain benign with their host but most of them will 
lead to either mild or life-threatening diseases. Some pathogenic viruses and their 
vectors are listed in Table 1.6 (Wagner et al., 2004). 
 
Table 1.6 Some pathogenic viruses and their vectors 




contamination of water 
Human 
 
Enteric infection, in rare 
cases CNS infection 
HIV 
 






Measles Aerosol Human Skin rash, neurological 
involvement 





Mild to severe 
hemorrhagic disease 
Hepatitis B Direct injection of 
blood 




Bite of infected animal 
Saliva, other secretions 
Vertebrates 
Human 
Fatal encephalitis Surface 
lesions follwed by 
latency, rare encephalitis 
Epstein-Barr 
(EBV) 
Saliva Human Infectious 
mononucleosis, latency 




For some of the viruses, their antigenic stability and lack of immune evading 
mechanisms made them relatively easy to be eradicated from the population. For 
example, smallpox virus has been eliminated from the population with effective 
vaccination programs and polio and measles are current candidates for partial or total 
elimination from the population due to the availability of effective vaccines. However, 
not all viral diseases can be readily controlled even under the most favorable 
economic and social conditions. Flu virus variants arise by genetic mixing of human 
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and animal strains. HIV remains associated with lymphatic tissue in infected 
individuals, this association makes vaccination and treatment only partially effective. 
Herpesvirus establishes latent infections and can reactivate in any time; this kind of 
latency makes it difficult to generate a completely effective vaccine (Wagner et al., 
2004). Until now many virus-derived diseases are far from eradicated. 
  
1.5.2 Kinases and Phosphatases as Anti-viral Drug Targets 
1.5.2.1 Cyclin-dependent Kinases (CDKs) as Novel Targets for Antiviral Drugs 
CDKs are a family of well conserved serine/threonine protein kinases that 
usually phosphorylate a serine or threonine followed by a proline. CDK1, 2, 3, 4, 6 
and 7 are involved in regulation of the cell cycle. Because most viruses replicate in 
dividing cells and it has been found that replication of HIV, HTLV, KSHV, HCMV, 
VZV, HSV-1, HSV-2, EBV, adeno- and other viruses require CDK activities, 
pharmacological CDK inhibitors (PCIs) are widely applied in antiviral drug research. 
Expectedly, viral replication functions of these viruses are efficiently inhibited by 
PCIs in cultured cells (Chao et al., 2000; Wang et al., 2001; Taylor et al., 2004; 
Schang et al., 2002). Moreover, CDK2 was demonstrated to be a non-essential kinase 
for mammalian cells. Knock outs of CDK2 in mice just show a single phenotypic 
defect-inhibition of meiosis (Ortega et al., 2003). Thus it is not surprising that PCIs 
are apparently well tolerated by animals and humans and are regarded as potential low 
toxic drug candidates.   
 
Because PCIs display these antiviral activities in vitro at concentrations that 
appear to have only limited negative side effects in vivo, PCIs are now scheduled to 
enter clinical trials as antiviral drugs. Recently, Flavo and Rosco, two members of 
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PCIs, ameliorated pathogenesis in a transgenic mouse model of HIV, and only a non-
statistically significant tendency to lymphopenia was identified after 21 days of 
treatment (Gherardi et al., 2004; Nelson et al., 2003). Although much progress has 
been made in the past few years, several important questions remain unanswered. For 
example, the ability of PCIs to inhibit viral replication in vivo at non-toxic 
concentrations is still unknown; all antiviral PCIs inhibit several protein kinases that 
could mediate their antiviral activities but with unknown mechanism. It is still not 
clear how these inhibitions of CDKs will influence the patients. Thus it requires more 
research investigation to prove PCI is an effective and safe antiviral drugs.   
 
1.5.2.2 PP1/PP2A as Antiviral Drug Targets 
Type 1 (PP1) and type 2A (PP2A) Ser/Thr protein phosphatases are major 
regulators of cell dephosphorylation. Binding of PP1 catalytic subunit (PP1c) to 
specific regulatory subunits generates a large family of PP1 holoenzymes (Cohen, 
2002). For PP2A protein family, the catalytic PP2Ac subunit associates with a 
structural PP2A-A subunit to form a dimeric core enzyme that interacts with the 
variable regulatory (B) subunit (s) (McCright et al., 1996) and confers substrate 
specificity to the dephosphorylating activity. 
  
Viruses have developed specific antitransforming strategies to deregulate cells 
via PP2A and PP1. Interaction of the PP2A-A subunit with small t-antigen encoded 
by transforming papovaviruses activates MEK/ERK, two major components of the ras 
transforming pathway (Sontag et al., 1997). The interaction between PP2A-B  
subunit and adenoviral protein E4orf4 induces cancer-cell specific apoptotic pathways 
(Shtrichman et al., 1999). Moreover, the DP71L protein of African swine fever virus 
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(ASFV) interacts with PP1 and activates its phosphatase activity (Rivera et al., 2007). 
HIV Tat protein binds with PP1 and targets PP1 to the nucleus, which probably 
dephosphorylates the C-terminal domain of RNA polymerase-II and CDK9 which 
help HIV-1 transcription (Nekhai et al., 2007).  
 
PP1 and PP2A have been found to play important roles in different viruses, 
however, they also play critical roles in normal cells and inhibition of these 
phosphatases will cause serious effects. Thus, how to specifically inhibit or modulate 
PP1 and PP2A expressed in virus-infect cells will be a bottleneck in the development 
of phosphatase-based antiviral drug research. Recently, several specific short peptides 
have been investigated in model systems (Guergnon et al., 2006). These peptides 
selectively block the interaction of the PP1 or PP2A core catalytic subunit with their 
local regulatory partners using delivered competing peptides to prevent specific 
substrate dephosphorylations. These, together with inhibitors, are regarded as valuable 
antiviral drug candidates. 
 
 
1.5.2.3 Virus-encoded Kinases and Phosphatases as Antiviral Drug Targets  
Comparing with previous host-encoded kinases and phosphatases, virus-
encoded kinases and phosphatases have their own advantages as antiviral drug targets. 
Due to the differences between virus-encoded and host-encoded enzymes (kinases and 
phosphatases), it is possible to design inhibitors specifically against virus-encoded 
kinases and phosphatases. On the other hand, the effects of such inhibitors have been 
limited to certain virus families due to the high variability of virus-encoded kinases or 
phosphatases. One example is the herpes simplex virus (HSV) UL13 protein kinase, 
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This kinase is highly conserved across the different herpesvirus subfamilies (alpha-, 
beta-, and gammaherpesviruses) (Smith et al., 1989). Knockdown of the Epstein-Barr 
virus (EBV) BGLF4 gene product reduces the infectivity of released virus and inhibits 
the production of infectious virus (Gershburg et al., 2007). Thus BGLF4 gene product, 
as a unique protein kinase, is a potential target for antiviral therapy. Another example 
is the Vaccinia virus (VV) H1 gene product (VH1) which was identified as a dual-
specificity protein tyrosine phosphatase (DS-PTPase) (Guan et al., 1991). Recently it 
has been found that VH1 blocks the activation of Stat1 by dephosphorylation of Stat1 
and blocks the IFN-γ signal cascade. This was believed to be evolved by Vaccinia 
virus to evade the immune system and VH1 was also regarded as a potential antiviral 
drug target (Najarro et al., 2001).  
 
1.5.2.4 Iridovirus-encoded Kinases and Related Regulators as Anti-iridovirus 
Drug Targets     
Unlike other large DNA viruses, frog virus 3, a type virus in Iridoviridae 
family, contains at least 20-fold higher specific activity of protein kinase than several 
other animal viruses such as Rauscher murine leukemia virus, Herpes simplex virus, 
Vaccinia virus and Reovirus (Silberstein et al., 1973). This Ser/Thr protein kinase was 
identified as a virus-encoded protein kinase (Silberstein et al., 1976). Recently nine 
members of iridoviridiae family were sequenced and two conserved Ser/Thr protein 
kinases were identified (Eaton et al., 2007).   
 
Our lab has identified a large number of structural proteins from SGIV in 
which ORF039L is a highly abundant structural protein, which is conserved in all nine 
sequenced iridovirus genomes (Song et al., 2006; Eaton et al., 2007). This viral 
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protein kinase has many substrates in purified virions and its specificity is quite 
unique (Silberstein et al., 1976; Aubertin et al., 1980). This suggests that this unique 
protein kinase plays critical roles in iridovirus infection and it represents a potential 
anti-iridovirus drug targets.  
 
1.6    Objectives and Significance of the Project 
SGIV genome has been sequenced and the proteomics studies of purifed 
virion have revealed 61 virus-encoded proteins. 17 of them are identified by all 
proteomics methods which suggested that these proteins are relatively abundant virus 
proteins (Song et al., 2004; Song et al., 2006). The objects of this project are: 
1. To set up knockdown platform for this virus. 
2. To screen viral structural genes with established knockdown platform. 
3. To explore the function of some of these essential viral proteins to reveal some of 
the basic mechanisms on virus infection.  
 
Previously we have identified 61 virion proteins in purified SGIV virion. 
SGIV genes, encoding these proteins, are selected for knockdown experiments to 
elucidate the function of these virus-encoded proteins. This should provide a better 
understanding of infection, replication, and assembly mechanism of iridovirus and 
iridovirus-host interaction. Moreover, we intend to further identify some unique 



















































Previous studies in our lab have elucidated the whole genome sequence of 
SGIV and 162 ORFs were predicted (Song et al., 2004). Subsequent proteomics 
studies have identified a total of 61 viral proteins from purified virions with three 
different proteomics methods. Some of these ORFs were identified by only one 
proteomics method, for example, ORF013R was only identified by 1D SDS-PAGE 
MALDI TOF PMF approach and ORF006R was only identified by 1D SDS-PAGE 
MALDI-TOF MS/MS approach, which would suggest that these ORFs might not 
encode viral proteins or they are not major components in mature virions. A total of 
seventeen ORFs were detected by all three proteomics methods which suggested that 
these 17 viral proteins were relatively abundant in mature virions and were readily 
identified by mass spectrometry (Song et al., 2006). These 17 ORFs are ORF012L, 
ORF016L, ORF018R, ORF026R, ORF039L, ORF046L, ORF055R, ORF060R, 
ORF069L, ORF072R, ORF075R, ORF078L, ORF084L, ORF089L, ORF090L, 
ORF101R, and ORF156L.  
 
Table 2.1 shows that ORF055R, ORF060R, ORF072R, ORF078L, ORF084L 
are homologous with other known proteins. ORF012L, ORF016L, ORF018R, 
ORF026R, ORF039L, ORF069L, ORF075R, ORF089L, ORF090L are novel proteins 
conserved in the Family Iridoviridae. ORF046L, ORF101R, ORF156L are novel 
proteins existing only in SGIV. Finally ORF012L, ORF018R, ORF026R, ORF039L, 
ORF055R, ORF069L, ORF072R, ORF075R, ORF082L, ORF093L, ORF101R, 
ORF135L, ORF140R, ORF156L were chosen as the knockdown targets. In order to 
explore the function of these structural proteins, antisense morpholino oligonucleotide 


















Homolog with Known 
Proteins 
ORF012L 1024 117.36 Yes No 
ORF016L 413 46.26 Yes No 
ORF018R 285 32.32 Yes No 
ORF026R 566 63.32 Yes No 
ORF039L 1051 118.22 Yes No 
ORF046L 248 23.77 No No 
ORF055R 240 22.77 No Adhesin 
ORF060R 970 109.56 Yes NTPase 
ORF069L 548 61.88 Yes No 
ORF072R 463 50.53 Yes Major Capsid Protein 
ORF075R 178 19.96 Yes No 
ORF078L 790 88.16 Yes Tyrosin Kinase 
ORF084L 375 41.64 Yes RNase III 
ORF089L 390 45.59 Yes No 
ORF090L 373 43.48 Yes No 
ORF101R 313 35.03 No No 








2.2 Materials and Methods 
2.2.1 Cells and Viruses  
Grouper embryonic cell line from the brown-spotted grouper Epinephelus 
tauvina (Chew-Lim et al., 1994) was cultured in Eagle’s minimum essential medium 
containing 10% fetal bovine serum, 0.116 M NaCl, 100 IU of penicillin G/ml and 
100uL of streptomycin sulfate/ml. Singapore Grouper Iridovirus (SGIV) was isolated 
from diseased grouper (Qin et al., 2003). Infectious viruses in cell culture medium 
from SGIV- infected grouper embryonic (GE) cells were divided into groups and 
stored at -80°C for all inoculations. Purification of the SGIV virion was described 
previously (Song et al., 2004). 
 
2.2.2 Antibodies 
PCR fragments representing ORF018R, ORF093L and ORF140R were 
amplified as described previously (Song and Hew, 2004) and digested with restriction 
enzymes.  
Primers for viral genes cloned into pGEX-6p-1: 
ORF018R:  5’-GCGAATTCATGTCCGTAAAACTATCTGAACGC 
                     3’-CCCTCGAGTTAATTTTGAGCTGTTCTGGGG 
 
ORF093L:   5’- TAAGGATCCATGGACTATTCGTCTGCTTACA 
                      3’- CGGAATTCTCAAATTTGGTCGTCGTTTG 
 
Primers for viral genes cloned into pET-15b:  
ORF140R: 5’-GGAATTCCATATGATGTCAGAATTTAGGGGTCATTATA 
       3’- CCGCTCGAGCTACGCTTTTTTATCCGCTT 
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ORF018R and ORF093L were cloned into pGEX-6p-1 and ORF140R was 
cloned into pET-15b. The recombinant GST fusion proteins were purified with 
glutathione-Sepharose 4B beads (Pharmacia). For GST-ORF093L the fusion proteins 
were eluted directly from the beads and subjected to SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) analysis. The fusion protein was used to raise mouse 
anti-ORF93 polyclonal serum. For GST-ORF018R the beads were incubated with 10 
cleavage units per milligram of the PrecissionTM protease at 4°C for 16h. The eluted 
ORF018R was passed through a SuperdexTM 75 column (Pharmacia) to remove the 
PrecissionTM protease and GST. The recombinant His-140 was purified with Ni-NTA 
agarose beads (Qiagen) and was passed through a SuperdexTM 75 column (Pharmacia). 
The purified ORF018R and His-ORF140R were applied to produce the rabbit anti-
ORF018R and anti-ORF140R polyclonal serum. The monoclonal antibody (MAb) 
against phosphoserine was from Qiagen. The monoclonal antibody (MAb) to actin 
was from Chemicon. Horseradish peroxidase-conjugated donkey anti-mouse and 
donkey anti-rabbit polyclonal antibodies were from Pharmacia. 
 
2.2.3 AsMO Design and Transfection  
Antisense morpholino (asMO) design was based on the full sequenced genome 
and predicted ORFs (Song et al., 2004). The designed asMOs were list in Table 2.2. 
Moreover, all the sequences were screened with BLAST 
(http://www.ncbi.nlm.nih.gov/BLAST/) against the whole database to preclude any 
unintentional gene-silencing effects. Negative-control asMO is the standard control 
oligo from GeneTools. AsMOs were delivered with Nucleofactor® kit (Amaxa) at 
20µM. All asMOs were synthesized and purified by GeneTools. 
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Table 2.2 Designed asMOs 
Knockdown Target Synthesized asMO Target Location 
Control CCTCTTACCTCAGTTACAATTTATA  
ORF012L  TTGAAGTTCTTTGACAGTCACCATC  -1-- +24 
ORF018R  GCGTTCAGATAGTTTTACGGACATC  -1-- +24 
ORF026R  CTTTTGACATTTGTATAGTTGCCAT  0 -- +25 
ORF039L  ATACGTTGCTCAGATTATCAGCCAT  0 -- +25 
ORF055R  GCAAAATAATGCGTAAAGTGCTCAT  0 -- +25 
ORF069L  TTGCGTGAAGGTATTTAGTTGCAT  0 -- +24 
ORF072R  CGCCAGCACCCGTTGTACAAGTCAT  0 -- +25 
ORF075R  CTCCGAAAATATCGTCGATATCCAT  0 -- +25 
ORF082L  TACTGCTGCGTTAGGAGGGTTCAT 0 -- +24 
ORF093L  ATTTGTAAGCAGACGAATAGTCCAT 0 -- +25 
ORF101R  GTCGCTCTGAGCTAATTACAGACAT  0 -- +25 
ORF135L  AATACGCTTGTACGAGTTCTTCCAT  0 -- +25 
ORF140R  GACCCCTAAATTCTGACATTTTTAT  -6 -- +19
ORF156L  ATTGTAAATCGTTCTTGTATGACAT  0 -- +25 
 
 
2.2.4 Radiolabeling of Newly Synthetic Proteins from Virus Infected Cells 
The GE Cell Line was infected with SGIV at a multiplicity of infection of 5. 
The inoculum was replaced at 24h postinfection (p.i.) with 90% methionine-free 
MEM, 10% Fetal Bovine Serum, containing 25µCi of [35S]-methionine. The cells 
were collected at 48h postinfection (p.i.). 
 
2.2.5 Viral Protein Analysis  
SGIV-infected cells were collected, pelleted, and resuspended in PBS. Lysates 
were prepared by sonication and centrifuge and were quantified with Coomassie 
Protein Assay kit (Pierce). The same amount of lysates from control and ORF018R 
knockdown group were loaded for gel electrophoresis and analyzed by a Western blot 
assay. Similarly the same amounts of lysates containing 35S-labeled proteins were 
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loaded for gel electrophoresis and were detected by autoradiography. 
 
For Western blot analysis, proteins were transferred from gels onto 
nitrocellulose membranes, and the blots were soaked in Tris-Buffered Saline Tween-
20 (TBST) containing 2% bovine serum albumin (BSA) and incubated at 25oC with 
the indicated primary antibodies in TBST followed by incubation with secondary, 
species-specific, horseradish peroxidase-conjugated antibodies. The peroxidase 
activity was developed by the Supersignal® West Pico Luminol Enhancer Solution 
and the Supersignal® West Pico Stable Peroxide Solution (Pierce) according to the 
manufacturer’s instructions. 
 
2.2.6 Detection of Viral Proteins by Immunofluorescence (IF)  
GE cells were grown to similar confluence (90%) on Lab-Tek® Chambered 
Coverglass (Nalge Nunc), transfected with MOs, infected with SGIV 24h 
posttransfection with an MOI (multiplicity of infection) of 5. Cells were fixed at 36h 
p.i. with 3% paraformaldehyde, permeabilized with 100% methanol, and then 
incubated with mouse polyclonal antisera prepared against ORF093L (1:200). Anti-
mouse AlexaFluor488-conjugated antibody was used as secondary antibody. DsDNA 
were stained with Hoechst (Invitrogen). Fluorescence was detected with an Olympus 
FV500 confocal microscope. Images were processed with Adobe PhotoShop version 
7.0. 
  
2.2.7 2D Gel Electrophoresis 
Uninfected cells and SGIV-infected cells (48h p. i.) were collected, pelleted, 
and resuspended in lysis buffer (2M thiourea, 7M urea, 4% CHAPS, 30mM Tris-Base) 
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which was premixed with Halt protease inhibitor mixture (EDTA-free) and 
endonuclease (Sigma). Sample mixture was vortexed and incubated for 30 min at 
room temperature followed by centrifugation at 18000×g at 4°C for 90 min. The 
supernatant was quantified with Coomassie Protein Assay kit (Pierce) using BSA as 
the standard. 2D electrophoresis was performed as previously described (Bi et al., 
2006). For each gel 150µg of protein sample diluted in 300µl of rehydration buffer 
(7M urea, 2M thiourea, 4% CHAPS, 20mM DTT, 0.5% IPG buffer pH 3-10 
(Amersham Biosciences)) were loaded. 
 
2.2.8 Gel Staining and Image Analysis 
All gels were fixed in a fixation solution (50% methanol, 10% acetic acid) for 
at least 1 h and then stained according to the modified silver staining method (Blum et 
al., 1987). The gels were scanned in a Bio-Rad GS-710 densitometer using 
PDQUEST 7.3 software (Bio-Rad). Image analysis was carried out with PDQUEST 
7.31 2D software package (Bio-Rad) including the quantitative analysis. At least three 
replicates of each sample pair were compared and the gel images were normalized 
based on the total spot volume of each gel. 
 
2.2.9 Trypsin Digestion and MALDI-TOF/TOF MS and MS/MS Analyses 
 Spots of interest were excised and digested with sequencing grade modified 
porcine trypsin (Promega) as described previously (Huang et al., 2002). MS and 
MS/MS spectra were obtained using the ABI 4700 Proteomics Analyzer MALDI-
TOF/TOF mass spectrometer (Applied Biosystems). The MS together with MS/MS 
spectra were searched against the whole NCBI database using MASCOT 2.0 (Matrix 
Science). Searches were performed without restriction of protein Mr or pI and with 
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2.3.1 AsMO Delivery Efficiency   
AsMOs are short chains of about 25 morpholino subunits. Each subunit is 
comprised of a nucleic acid base, a morpholine ring and a nonionic 
phosphorodiamidate intersubunit linkage. Unlike DNA and RNA, which carries 
negative charge in biological system, morpholino carries no charge. In order to deliver 
asMO into the GE Cells with high efficiency, nucleofactor technology was applied. 
First the transfection efficiency was optimized with protocols and pmaxGFPTM 
provided from Amaxa. The optimized program was T-27 and the optimized buffer 
was buffer T (Amaxa). In order to check whether asMO delivery has the same 
efficiency with vector delivery in the GE Cell Line, standard control asMO with 3’-
Carboxyfluorescein (Gene-tools) was delivered at 20µM with Buffer T, Program T-27 
(Figure 2.1). A total of 69 cells could be identified from Figure 2.1C and 61 of them 
could be identified with fluorescence in Figure 2.1D, thus the estimated delivery 
efficiency was 88%. Because Carboxyfluorescein labeled on standard control asMO 
was not stable and could be easily degraded in vivo, some of the cells delivered with 
low concentration of asMO might not be identified with the fluorescence microscopy. 
Thus the actual delivery efficiency of asMO should be higher than 88% and met the 
requirement of viral knockdown study.  Because virus will infect 100% cells, at least 
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Figure 2.1 AsMO delivery efficiency in GE Cell Line 
 
asMO93 (A and B) and asMOctrl with 3’-Carboxyfluorescein (C and D) were delivered 
with the same conditions. After one hour, Figures A and C were recoded with phase 
contrast mode and Figures B, D were recoded with fluorescence mode in an Axiovert 







2.3.2 Viral Protein Expression Analysis with Autoradiography 
Because we do not have antibodies for all target proteins, medium containing 
[35S]-methionine was applied to screen knockdown effect of the designed asMOs 
(Figure 2.2). The selected 14 ORFs were blocked individually and the knockdown 
effect was verified by autoradiography. Only knockdown of ORF012L and ORF018R 
could be detected by autoradiography (Figure 2.2). These could probably be explained: 
1. AsMO did not bind with the target mRNA and the expression of target proteins 
were not blocked. 2. The target protein expression level was too low to be detected by 
SDS-PAGE autoradiography.   
 
Comparing uninfected samples with infected samples, most of the host protein 
expressions were blocked by SGIV infection. This was in accord with previous 
observation that Frog Virus 3 could shut down host macromolecular synthesis 
(Williams, 1996). Thus the isotope-labeled proteins were mainly viral proteins. 
Among these labeled proteins only about twenty major bands could be distinguished 
from SDS-PAGE autoradiography which limited the application of this method. 
Compared with previous MS identified viral protein on one-dimensional SDS-PAGE 
(Song et al., 2004), some of major bands could be annotated as viral proteins. Thus 
autoradiography was a preliminary method to examine protein knockdown effect in 
the absence of any specific antibodies. 
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Figure 2.2 AsMO knockdown effects examined by autoradiography 
 
The GE cells transfected with B (asMOctrl), C (asMO12), D (asMO26), E (asMO75), G 
(asMO18), H (asMOctrl) were infected 24h posttransfection (MOI=5), the medium was 
refreshed with the special medium containing 35S-labeled methionine after 24h 
infection. Lane A and Lane F were uninfected control. Total cell lysates prepared at 
48h p.i. were analyzed by gel electrophoresis and autoradiography. 20µg total cell 




















Figure 2.3 AsMO knockdown effects checked by Western blot assay 
 
The GE cells transfected with asMOctrl, asMO18, asMO93 and asMO140 were infected 
24h posttransfection (MOI=5). Total cell lysates prepared at 48h p.i. were analyzed by 









2.3.3 Viral Protein Expression Analysis with Western Blot Assay 
The antibodies against ORF018R, ORF093L and ORF140R were successfully 
raised and the knockdown effect of asMO18, asMO93 and asMO140 were analyzed by 
Western blot assay (Figure 2.3). The results showed that knockdown effect of asMO18, 
asMO93, asMO140 were significant, confirming that the asMO was delivered 
successfully by Nucleofactor technology.  
 
2.3.4 Viral Protein Expression Analysis with Immunofluorescence 
The intracellular distribution of ORF093L was evaluated by IF staining of 
infected cells at 36h p. i. with antisera specific for ORF093L. The analysis showed 
that ORF093L was co-localized with Hoechst staining area. In the late iridovirus 
infection stage, viromatrix which was a factory for viral genome replication and 
particle assembly was formed (Huang et al., 2006), thus Hoechst would stain both the 
viromatrix and the cell nucleus. Unlike the cell nucleus, viromatrix contained many 
copies of viral genome which were much smaller than the cellular chromosomes. 
Figure 2.4 showed that ORF093L might be localized in viromatrix and asMO93 had an 
excellent knockdown effect for ORF093L expression (For the intracellular 
























Figure 2.4 AsMO93 knockdown effects checked by immunofluorescence 
 
The GE cells transfected with asMOctrl, asMO93 were infected 24h posttransfection 
(MOI=5). At 36h p.i., the monolayers were processed for IF assay using the primary 
antibody anti-93 and Alexa-488-conjugated secondary antibodies (green). 
Colocalization of signals is indicated by blue-green and cell dsDNA were visualized 











2.3.5 Comparison between Uninfected and Infected Cell 2D Maps and the 
Identification of Some SGIV Viral Proteins with MS Analysis. 
In order to understand the phenotypic changes caused by certain viral genes 
knockdown, uninfected and infected cell lysates were prepared and analyzed by 2DE 
gel-MS. Some of virus and host proteins were identified by MS (Table 2.3). The 
results showed that (1) the protein profiles were not significantly changed by virus 
infection. (2) Some of viral and host proteins had more than one isoforms which could 
be separated by 2D gel (Figure 2.5).    
 
Although iridovirus would turn off the host macromolecules syntheses 
(Williams, 1996), our results showed that the production of most host proteins still 
existed in iridovirus-infected late stage cells and the significantly altered spots which 
could be identified by PDQuest were less than 20% of total spots. These changed 
spots come from newly emerged virus-encoded proteins, degraded host proteins, and 
change of posttranslational modifications (such as phosphorylation and 
ubiquitylation). Iridovirus encoded their own ubiquitin which is generally regarded as 
a small conserved regulatory protein involved in labeling proteins for proteasomal 
degradation, thus some of host proteins which were harmful for virus infection might 
be degraded in iridovirus infection process. Several spots sometimes represented one 
protein on 2D gel, this suggested that these proteins may have different 
posttranslational modified isoforms or some spliced variants. These 2DE gels had 
been annotated and identified some proteins in infected cell lysates which would be 
helpful for the next knockdown screen. Moreover, ORF111R was a novel viral protein 
























Figure 2.5 Comparison between uninfected cells and infected cells and identification 
of some proteins in infected cell lysates with mass spectrometry 
Uninfected cell lysates (A) and infected cell lysates (B) were treated and loaded for 





























1 ORF0140R [SGIV] gi|56692777 32177 4.85 5 427 357 26 
2 ORF018R [SGIV] gi|56692655 32703 6.01 7 504 401 50 
3 ORF0156R [SGIV] gi|56692793 31218 5.6 5 269 177 40 
4 5 362 270 47 
5 5 272 192 46 
6 7 387 295 46 
7 
ORF075R [SGIV] gi|56692712 19949 4.5 
5 234 168 38 
8 eIF-5Aa gi|47209413 17558 5.18 2 190 176 8 
9 cofilin 2a gi|45387807 
 
18728 7.62 2 166 144 21 
10 5 281 259 30 
11 
cofilin 2a gi|47225278 
 
18856 6.82 
4 277 249 30 
12 5 489 413 66 
13 6 546 467 63 
14 
dUTPase [SGIV] gi|56692686 
 
17106 6.51 
5 491 402 61 
15 nucleoside diphosphate kinasea 
gi|30142116 
 
17328 5.93 4 287 210 45 







2 131 52 53 
18 3 209 130 42 
19 
natural killer 
enhancing factora  gi|63002583 22156 6.82 3 150 130 20 
20 natural killer enhancing factora  
gi|61806512 
 
22207 6.42 2 67 52 18 
21 ORF125R [SGIV] gi|56692762 
 
21648 5.91 1 122 65 43 
22 ORF111R [SGIV] gi|56692748 
 
29732 5.47 3 128 73 41 
 
 
adue to the unavailability of the genome of the host grouper fish, all the host 





2.4.1 The Limitation of This Platform 
Because SGIV genome is a large viral genome which consists of 140,131 
nucleotide bp (Song et al., 2004), it is quite difficult to construct deletion mutations 
because too few information about iridovirus replication in host. Thus we tried to 
knock down selective SGIV proteins with antisense technology. AsMO, as a popular 
knockdown technology, has been widely applied in zebrafish developmental biology. 
Here we showed that asMO also worked quite well in the GE Cells and at least the 
expression of three viral proteins, ORF018R, ORF093L and ORF140R were 
successfully inhibited in virus infection. Figure 2.6 showed the flowchart of this 
platform.  
 
However, just like many other biological methods, this platform also has 
several disadvantages:    
1. AsMO normally targets at 5’-UTR and the first 25 nucleotides of the coding 
regions of mRNA. However, we sequenced numerous viral mRNA with 5’-RACE and 
found that most SGIV mRNAs only had a very short 5’-UTR that overlaps with ORFs 
upstreams in the viral genome. Moreover, analysis of SGIV genome showed that 
upstream of viral late genes had a similar poly A region. This phenomenon has limited 
asMO applications in our viral proteins knockdown study. Most of asMOs targeting 
viral ORFs had to be complementary with the first 25 nucleotides of coding regions of 
viral mRNA. For many ORFs, the starts of their coding regions were not suitable as 


























Figure 2.6 Flowchart of the knockdown platform for SGIV 
 
 
asMO sequence design Get 5’UTR information 
of viral proteins with 5’ RACE 
asMO 
Delivery  
Deliver asMO into the Grouper 
Embryonic Cells with 





Knockdown quality control 
Phenotype change detection 
Titer assay 
Detect phenotype change 
with light microscopy 
Detect phenotype change 
with EM 
Detect phenotype change with
confocal microscopy 
Detect phenotype change with 
2D electrophoresis 
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The asMO design has many other restrictions: 
A. High G oligo 
High G content decreases the aqueous solubility of a Morpholino oligo and the design 
guidelines from genetools recommend a maximum G content of 36%.  
B. Low CG oligo 
The minimum CG recommended by the company’s guideline is 40%. The asMO with 
less CG content will have less affinity for its mRNA target.    
C. Self-complementarities 
The maximum stability allowed by the company’s guideline for a self-
complementarity is 16 contiguous hydrogen bonds. Stable self-complementarities can 
cause asMOs to form dimers, reducing antisense activity.  
D. G quartet 
Four or more contiguous G bases would form G quartets, where four oligo strands 
tetramerize through Hoogsteen bonding that would dramatically reduce antisense 
activity.  
All these restrictions had limited the application of asMO knockdown technology 
such that it might not be applicable for certain viral proteins. 
 
2. Just like other antisense technologies, the possibility of off-target effect 
could never be eradicated for certain asMO despite careful design. Moreover, unlike 
cellular proteins, many viral proteins have cellular toxicities which made it very 
difficult to do in vivo rescue experiments.   
 
3. SGIV, as a dsDNA virus, has a large genome as compared with other viruses. 
Gene redundancies are quite frequent in SGIV genome. Both ORF093L and 
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ORF140R have homologies in SGIV genome which might explain why knockdown of 
these two genes do not cause any obvious phenotype changes.     
 
2.4.2 Detection of Phenotypic Changes 
Two obvious phenotypic changes with certain viral proteins knockdown could 
be easily detected i.e. inhibition of virus infection and distortion of viral assembly. 
Other phenotypic changes might be difficult to be detected.  
 
2.4.3 Significances of This Platform 
To explore viral encoded protein functions and virus infection mechanisms, 
some cell lines and primary cells have been used (Fang and Pincus, 1999). However, 
many of these cells were difficult to be transfected which made it difficult to deliver 
vectors, SiRNAs, asMOs and some other knockdown agents. Our results show that 
nucleofactor technology, a new electroporation method, could give high delivery 
efficiencies for those cells refractory to transfection.       
 
Moreover, RNAi, identified as a unique cellular mechanism eight years ago, 
was found not to be suitable as antivirus reagents for many viruses (Fire et al., 1998; 
Li and Ding, 2006). Here we showed that artificial synthetic modified nucleotides 
could also be regarded as candidates for antiviral drug research.  
 
2.5 Conclusion    
In this work, a total of fourteen asMOs were designed to target fourteen viral 
late genes which included ORF012L, ORF18R, ORF26R, ORF39L, ORF55R, 
ORF69L, ORF72R, ORF75R, ORF82L, ORF93L, ORF101R, ORF135L, ORF140R 
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and ORF156L. All the genes knockdown effects were checked with autoradiography, 
three of them (ORF093L, ORF140R, ORF018R) were confirmed with western blot, 
one of them (ORF093L) was confirmed with immunofluorescence.  
 
In order to detect phenotypic changes, all the asMOs delivered cells were 
infected with SGIV and analyzed with viral titer assays and TEM observations. Only 
ORF018R knockdown showed obvious phenotypic changes, and the detail of 
































































In Chapter II we have designed and delivered morpholinos against 14 viral 
ORFs to screen viral essential genes. Knockdown of ORF018R, ORF093L and 
ORF0140R were confirmed by western blot and only knockdown of ORF018R 
caused obvious phenotypic changes. In this chapter we focused on ORF018R 
functional study and characterized certain iridovirus infection mechanisms by 
knocking down this protein. 
 
Previous study has revealed that many DNA viruses encoded their own protein 
kinases. For example, both iridovirus and herpesvirus encode serine/threonine kinases 
which are highly conserved in their families separately (Eaton et al., 2007; Gershburg 
et al., 2007) and herpesvirus encoded kinases are regarded as attractive targets for 
antiviral therapy due to their essential roles in virus infection and their uniqueness 
(Gershburg et al., 2007). Similarly, iridoviruses encoded protein kinases probably also 
play important roles in virus infection and are interesting targets for antiviral therapy.    
 
Protein phosphorylation/dephosphorylation plays critical roles in the 
regulation of cellular activities. Viruses often hijack cellular kinases or encode their 
own kinases to support numerous viral infection processes including transcription 
(Nekhai et al., 2007), translation (Mohr, 2006), assembly (Liu and Brown, 1993) and 
inhibition of apoptosis (Leopardi et al., 1997). Like many other DNA viruses, 
Iridovirus also encoded their own kinases and a protein kinase which could 
phosphorylate virion proteins was identified in purified Frog Virus 3 (a type 
vertebrate iridovirus) virion and was further proven to be a virus-encoded 
serine/threonine kinase thirty years ago (Silberstein et al., 1973; Silberstein et al., 
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1976). Bioinformatics analyses for nine sequenced iridovirus genomes unraveled that 
two serine/threonine kinases were highly conserved in Iridoviridae family (Eaton et 
al., 2007). Based on our previous proteomics study, one of these conserved 
serine/threonine kinases (ORF039L) was identified in purified SGIV virion with high 
abundance (Song et al., 2004; Song et al., 2006), which shared a high similarity with 
Frog Virus 3 ORF019R.  
 
The SGIV ORF018R gene product is a hypothetical protein that is conserved 
in Frog Virus 3, Tiger Frog Virus, Ambystoma Tigrinum Virus, Grouper Iridovirus 
and Singapore Grouper Iridovirus (Eaton et al., 2007). Blast analysis showed that this 
protein contains a partial serine/threonine kinase catalytic domain which suggests that 
it might be involved in phosphorylation processes. Moreover, this protein has been 
identified as an abundant virion protein in mature SGIV virions, which suggests it 
might have an important role in virus infection (Song et al., 2006). 
 
Here, Iridovirus phosphorylation was explored by knocking down of SGIV 
ORF018R expression with asMO technique. Immunofluorescent staining revealed 
that ORF018R was localized in the whole SGIV-infected late stage cells. The 
morpholino against ORF018R was delivered into grouper embroynic cells with 
Amaxa Nucleofaction technology and ORF018R expression was dramatically reduced. 
Reduced ORF018R expression resulted in (i) partial inhibition of viral late genes 
expression and block of virus infection, (ii) distortion of viral DNA packaging and 
virion assembly, and (iii) enhanced serine phosphorylation. Moreover, five enhanced-
phosphorylated proteins were identified with 2DE-MS analyses, which included three 
viral proteins: ORF075R, ORF086R and dUTPase (ORF049L), and two host proteins: 
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natural killer enhancing factor (NKEF) and eukaryotic translation initiation factor 3 
(eIF3) subunit-12. Furthermore, we found that purified SGIV virion could also be 
hyperphosphorylated by endogenous kinases and the potential kinase-ORF039R was 
cloned and purified (558-1051) which could phosphorylate rORF075R in vitro. Based 
on these studies, we propose that ORF039R and ORF018R are involved in 
serine/threonine phosphorylation regulation during SGIV infection late stage cells and 
ORF075R is one of the important regulated substrates. These phosphorylations play 
some important roles in virion assembly and viral late stage protein synthesis. 
 
3.2 Materials and Methods 
3.2.1 Preparation of Purified Truncated rORF039L 
PCR fragments representing different segments of ORF039L were amplified 
as described previously (Song and Hew, 2004) and digested with restriction enzymes.  
Primers for viral gene cloned into pGEX-6p-1: 
ORF039L:    5’- CGGGATCCATGTGCAATGAGCTAGAAAAC (558-forward) 
                     3’- CCGCTCGAGTTAAAATTCGTATCTATCGAT (1051-reverse) 
 
ORF039L (558-1051) were cloned into pGEX-6p-1. The beads bound with 
GST-ORF039L (558-1051) were incubated with 10 cleavage units per milligram of 
the PrecissionTM protease at 4°C for 16h. The eluted ORF039L (558-1051) was passed 
through a SuperdexTM 75 column (Pharmacia) to remove the PrecissionTM protease 





3.2.2 Preparation of Purified rORF075R 
 PET15b-ORF075R prepared by one of our team members, Tran Bich Ngoc, 
Ann. The construct was transformed into E.coli strain BL-21 (DE3) for protein 
expression. The transformed cells were cultured in LB with 100µg/ml of ampicillin, 
and 0.1mM IPTG was added when OD600 reached 0.6-0.8. After subsequent culture 
at 18°C for another 16 hours, the cells were harvested by centrifugation at 7000×g for 
20 min. The E.coli pellet was resuspended in lysis buffer (10mM Tris-HCl, pH7.0), 
sonicated at 4°C for another 3 min followed by centrifugation at 11000×g at 4°C for 
30 min. The supernatant of the lysates was loaded onto a Ni-NTA resin and shaked for 
60 min at 4°C. The ORF075R-bound resin was then washed with the lysis buffer 
containing 20mM imidazole for 100 bed volume. Finally the resin was eluted with 
10mM Tris-HCl, pH 7.0, 200mM Imidazole and the eluted ORF075R was diluted in 
10mM Tris-HCl 7.0 and the imidazole was removed with a concentrator (Millipore, 




Monoclonal antibody (MAb) against phosphoserine was from Qiagen. 
Monoclonal antibody (MAb) to actin was from Chemicon. Horseradish peroxidase-
conjugated donkey anti-mouse and donkey anti-rabbit polyclonal antibodies were 
from Pharmacia. 
 
3.2.4 Detection of ORF018R by Immunofluorescence (IF).  
GE cells were transfected with asMOs and grown on glass coverslips. The 
cells were infected at 24h posttransfection and fixed with 3% paraformaldehyde, 
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0.02% glutaradehyde at 48 h p. i., permeabilized with cooled methanol, and incubated 
with antibody against ORF018R (1:200). Anti-rabbit AlexaFluor594-conjugated 
antibody was used as the secondary antibody. DsDNA were stained with Hoechst 
33342 (Invitrogen). Fluorescence was detected with an Olympus confocal microscopy. 
Images were processed with Adobe PhotoShop version7.0.    
 
3.2.5 Titration of Viral Progeny and Light Microscopy. 
GE cells were transfected with asMOs, infected at 24h posttransfection with a 
MOI of 0.5. Redundant viruses were removed at 2 h p.i. and the cells were washed 
twice with PBS. At different time interval the monolayer cells were observed with 
Axiovert 200M (Zeiss). For each transfection, four parallel infections were performed. 
Viral supernatants of 5 different time-intervals were diluted from 10-2 to 10-7 and used 
to infect GE cells with 4 repetitions per dilution to perform the TCID50 assay. Viral 
titers were calculated as described by Spearman-Karber method (Hamilton et al., 
1977). 
 
3.2.6 Electron Microscopy Observation of SGIV Infected Cells 
GE cells were transfected with asMOs and infected with SGIV. The cells were 
fixed in 2.5% glutaraldehyde, 2% paraformaldehyde-PBS, postfixed with 1% osmium 
tetroxide, and embedded using the Spurr Kit (Sigma). The ultrathin sections obtained 
were stained with 2% uranyl acetate and 1% lead citrate. Ultrathin sectioned samples 
were examined with a Philips CM10 electron microscopy at 100 kv. 
 
3.2.7 Detection of Enhanced Serine Phosphorylation by Phospho-serine MAb 
Polyclonal antibody against ORF018R was raised as described in Chapter 2. 
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Monoclonal antibody (MAb) to actin was from Chemicon. Monoclonal antibody 
(MAb) against phosphoserine was from Qiagen. Western blot assays for actin and 
ORF018R detection were carried as described in Chapter 2. For phosphoserine 
detection, western blot was performed as suggested (Qiagen).  
 
3.2.8 Circular Dichroism (CD) Spectrum of rORF018R 
 The purified rORF018R were incubated with different concentrations of DTT 
and several metal ions for 5 min at room temperature in 10mM HEPES pH7.9, 
100mM NaCl. The experiment was conducted in the Far-UV range (190-260 nm) with 
Jasco spectrophotometer J-720 (Tokyo, Japan).  
 
3.2.9 Dynamic Light Scattering (DLS) Study of rORF018R 
 To assess the stability of rORF018R, the protein was characterized using 
dynamic light scattering (DLS) with DynaPro instrument (Protein Solutions Inc). The 
experiment was conducted at 4°C and the data were analyzed using Dynamics 5.0 
(Moradian-Oldak et al., 1998).  
 
3.2.10 Viral Endogenous Kinases Activity Assay 
 Purified SGIV (100µg proteins) was disrupted in 25mM Tris-HCl (pH 8.0) 
buffer, 10mM DTT, 0.5% NP40 at 30°C for 30 min, and proteins were 
phosphorylated by the addition of either 0.2mM ATP, 10mM MgCl2 or 0.2mM ATP 
10mM MgCl2 1mM MnCL2 in 200 µl final vol. and incubation at 30°C for 15 min. 
The reaction was stopped by the addition of SDS loading dye (250mM Tris-HCl pH 
7.0, 50% glycerol, 0.5% Bromophenol Blue, 20% SDS, 200mM DTT). The samples 
were loaded for SDS-PAGE and the gel was stained with ProQ DiamondTM 
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(Invitrogen) and silver staining (Chapter II) in sequence. The ProQ DiamondTM 
stained gel was scanned with Typhoon 9200 (Ex: 580nm, Em: 620nm) and the silver 
stained gel was scanned with a Brother DCP-115C scanner.   
 
3.2.11 Purified Viral Kinase Activity Assay 
 Purified rORF075R (1µg) was phosphorylated by the addition of (1) 1mM 
ATP, 10mM MgCl2 (2) 1mM ATP, 10mM MgCl2, 1µg purified rORF018R (3) 1mM 
ATP, 10mM MgCl2, 1µg purified rORF039R (558-1051) in 10 µl final vol. The 
reaction mixtures were incubated at 25°C for 10 min and treated and analyzed as 
described in 3.2.10. 
 
3.2.12 Trypsin Digestion and Linear Ion Trap Orbitrap (Thermo)-MS and 
MS/MS Analyses 
 Spots of interest were excised and digested with sequencing grade modified 
porcine trypsin (Promega) as described previously (Huang et al., 2002). MS and 
MS/MS spectra were obtained using the Linear Ion Trap Orbitrap mass spectrometer 
(Thermo). The MS together with MS/MS spectra were searched against the whole 
NCBI database using MASCOT 2.0 (Matrix Science). Searches were performed 
without restriction of protein Mr or pI and with mandatory carbamidomethylation of 
cysteines and variable oxidation of methionine and phosphorylation of serine, 







3.3.1 Intracellular Distribution of ORF018R in SGIV Infected Cells  
Knockdown of ORF018R has been previously confirmed by western blot and 
autoradiography. In this chapter, the intracellular distribution of ORF018R was 
evaluated by IF staining of infected cells at 48 h p. i. and the knockdown effect of 
ORF018R was further confirmed by IF staining. Iridovirus-infected cell normally has 
a viromatrix which is a viral particle assembly center (Huang et al., 2006). DsDNA 
staining revealed that viromatrix formed in the SGIV-infected late-stage cells and 
ORF018R expression was mainly distributed in the cytoplasm, probably in the 
viromatrix (Figure 3.1). This suggested that ORF018R probably was involved in virus 


































Figure 3.1 Intracellular distribution of ORF018R. 
GE cells were transfected with asMOctrl and asMO18, infected with SGIV (MOI=5) at 
24h posttransfection. The monolayers were fixed at 48h p. i., permeablized with 
cooled methanol and processed using the indicated combination of primary antibody 
and Alexa-594-conjugated secondary antibody (red) and the cellular dsDNA was 






3.3.2 Effect of ORF018R Knockdown on Particle Formation 
The morphology of virus particles assembled in the presence of asMO18 was 
examined by transmission electron microscopy (TEM). After mature viruses were 
assembled in viromatrix, part of them would bud out of the cells and with this process 
the virus gained its envelop (Qin et al., 2001). Figure 3.2-A1, B1 were representatives 
of transfected SGIV-infected late stage cells with asMOctrl and asMO18 delivered 
respectively. Figure 3.2-A2, B2 were magnified from the viromatrixes of Figure 3.2-
A1, B1 and Figure 3.2-A3, B3 were magnified from budding area of Figure 3.2-A1, 
B1. The EM samples were fixed at 48 h p. i. with a multiplicity of infection of 5, thus 
most of the infected cells were at late virus infection stage with a large viromatrix and 
most of these viruses in viromatrix were fully assembled. In order to exclude the 
possibility that the defective viruses shown in Figure 3.2-B were in the assemble stage 
of the virus, the budding virions from asMO18-transfected sample were captured 
(Figure 3.2-B3). Compared with the control virions (Figure 3.2-A3), the budding 
virions retained the capsid integrity but had a distorted viral DNA-protein complex 
core. More than 20 cells were counted for asMO18-transfected samples and more than 
90% budding virions had similar phenotypes with those showed in Figure 3.2-B3. 
Furthermore much fewer budding virions were observed in all cells in asMO18-
delivered group as compared with the control group. Normally immature virus does 
not bud out of the cells, thus the distorted virions observed in asMO18-transfected 





















Figure 3.2 Effects of ORF018R knockdown on SGIV assembly. 
GE cells transfected with (A) asMOctrl, (B) asMO18 were infected 24h posttransfection 
(MOI=5), and at 48 h p.i. the cells were fixed and prepared for electron microscopy. 
Viromatrix (V) was present in the cytoplasm of SGIV-infected cells. A2, B2 were 
amplified from A1, B1 viromatrix separately and A3, B3 were amplified from A1, B1 
virus budding area. The pictures shown were representative of at least 20 different 
virus-infected cells. Normal virus (arrows); Defective virus (arrow heads). For A1, B1: 
Magnification, Χ15500, Scale bars, 600nm; For A2, A3, A4, B2, B3, B4: 







3.3.3 Effect of ORF018R Knockdown on Virus Infectivity and Viral Protein 
Synthesis                  
To evaluate the reduction of SGIV infectivity with asMO18 knockdown, low 
MOI (0.5) and short infection time (2h) were performed. Previous DNA microarray 
results have shown that most of the viral genes commenced their transcriptions at 4 h 
p. i. (Chen et al., 2006). Thus after 2h of incubation, no infective mature viral 
progenies were produced. TCID50 analyses showed that the infective viral progenies 
in the supernatants of asMO18 delivered groups were much less than that of asMOctrl 
delivered groups. With low MOI infection the cells were mainly infected by the viral 
progenies produced from the first batch of infected cells. In this case obvious 
cytopathic effect emerged at 3 d p.i. for control 1 and 2 but at 6 d p.i. for ORF018R 
knockdown group (Figure 3.3) which suggested that knockdown of ORF018R may 
cause the reduction of viral progenies. Moreover, expressions of other viral proteins 
were also partially blocked in ORF018R knockdown group which was in agreement 
with the reduction of infective viral progenies (Figure 2.2, Figure 3.5). Because asMO 
must bind 14 to 15 contiguous bases to block a gene transcript (Summerton, 2007) 
and ORF018R knockdown target sequence was so unique that no continuous 14 
nucleotides was matched within the SGIV genome except the target sequence, the 
effect of the asMO18 was specific to ORF018R within SGIV. Furthermore, the 
uninfected GE cells with asMO18 delivered did not show any hyperphosphorylations 
(Figure 3.4), thus the asMO18 off-target effects should not contribute to all these 
phenotypic changes and the decreased expression of other viral proteins was a result 























Figure 3.3 Reduction of SGIV infectivity in asMO18 transfected cells 
Non-transfected GE cells (control1) and the GE cells transfected with asMOctrl 
(control2) and asMO18 (ORF018R) were infected (MOI=0.5). The infected cells were 
washed twice with PBS at 2 h p.i. and the inoculum was replaced with fresh culture 
medium. The supernatants from infected cell culture of 5 different time-interval 
groups were diluted from 10-2 to 10-7 and used to infect GE cells with 4 repetitions per 
dilution to perform TCID50 assay. The average titers of 5 time-intervals samples were 
shown in lgTCID50. The data shown in graphs represented averages for four parallel 
infection experiments with 2 standard deviations indicated by error bars. 
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3.3.4 Enhanced Serine Phosphorylations in ORF018R Knockdown Infected GE 
Cells 
Based on bioinformatics analyses, ORF018R was annotated as a putative 
serine/threonine kinase conserved in several iridoviruses (Eaton et al., 2007). To 
check the effect of ORF018R knockdown on phosphorylation/dephosphorylation of 
infected cells, the serine phosphorylations of viral proteins were evaluated by Western 
blot (Figure 3.4). Both quantifications of the cell lysates with Pierce kit and the anti-
actin control confirmed that the same amounts of cell lysates were loaded (Figure 3.4), 
thus enhanced serine phosphorylations were observed in ORF018R knockdown group 
and the significantly enhanced phosphorylated proteins were mainly located between 
17kDa and 32kDa (Figure 3.4).  
 
3.3.5 Standard 2DE-map of SGIV-infected Cells with AsMOctrl Transfected 
In order to explore ORF018R downstream proteins, 2DE-MS was applied and 
standard 2DE maps were run and compared (Figure 3.5). Figure 3.5 depicted the same 
area for three 2D gels generated respectively, emphasizing the high level of protein 
resolution and reproducibility achieved in this experimental process. The excellent 
reproduction in protein pattern and protein density between all three gels was evident 






































Figure 3.4 Enhanced serine phosphorylations with ORF018R knockdown 
GE cells were transfected with asMOctrl and asMO18. The uninfected cell lysates were 
collected at 24h posttransfection and the infected cell lysates were collected at 48 h p. 
i.. 30µg cleared cell lysates were loaded for each lane and cellular serine 
phosphorylations were analyzed by Western blot assay using phosphoserine, 
ORF018R-, actin-specific antibody. Enhanced serine phosphorylated proteins were 
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Figure 3.5 Demonstration of SGIV-infected GE cells 2D gel reproducibility between 
runs  
 
(A) GE cells were transfected with asMOctrl and infected with SGIV (MOI=5) at 24h 
posttransfection. The cells were collected at 48 h  p. i. and treated for 2DE map.  
















3.3.6 Identification of Enhanced Phosphorylated Proteins in ORF018R 
Knockdown Infected GE Cells 
In order to further clarify the enhanced-phosphorylation of proteins, 2DE-MS 
approach was applied. asMOctrl and asMO18 delivered GE cells were infected and 
analyzed with 2D gel electrophoresis (Figure 3.6). Specific regions in the 2D gel, 
corresponding to the enhanced protein phosphorylation region (Mr 17-32kDa) 
revealed by Western blotting were analyzed by Mass Spectrometry. Approximately, 40 
significantly altered spots were detected, lying mainly in the pI range of 4.5 to 7.0. 
However, only 22 spots, representing seven proteins, could be identified 
unambiguously by MS (Figure 3.6, Table 1). The remaining spots could not be 
identified and may represent proteins from host cells; failure to identify these spots 
may be due to the unavailability of the host grouper genome. 
 
Among seven identified proteins, five of them were SGIV proteins [ORF018R, 
ORF049L (dUTPase), ORF075R, ORF086R and ORF156L] and the other two (NKEF 
and eIF3 subunit 12) were host proteins which were identified by homology. The pI 
and Mr of host protein spots (NKEF and subunit 12 of eIF3 and their isoforms) by 
2DE were consistent with calculated theoretical values from the protein database.  
 
By comparing 2D gels for the control and the ORF018 knockdown group, it 
can be seen that the translation of the target gene was considerably decreased (spot 20, 
Figure 3.6A, and the black circled spot, Figure 3.6B), indicating that the knockdown 




2D gels also showed that the translation of another protein ORF156L (spot 18, 
Figure 3.6A, and spot19, Figure 3.6B) was partially blocked in the ORF018 
knockdown group. This was in accord with western blot results, which showed that 
viral late proteins translation was partially blocked by the ORF018R knockdown 
(Figure 2.3).  
 
Among other five identified proteins, ORF049 (dUTPase, spot 10, Figure 3.6A) 
not only appeared at a reduced level (spot 11, Figure 3.6B), but also was accompanied 
by its two new isoforms (spots 12 and 13, Figure 3.6B) with higher mass and lower pI 
in the knockdown group. Similarly, the host protein NKEF (spot 14, Figure 3.6A), 
showed decreased amounts (spot 15, Figure 3.6B), with emergence of its two new 
isoforms (spot 16 and 17, Figure 3.6B) with lower pI and higher MW.  
 
Both putative intermediate early (IE) gene-ORF086R (spot 21, Figure 3.6B) 
and eIF3 subunit 12 (spot 22, Figure 3.6B) were only identified in the ORF018R 
knockdown group. Because the predicted pI for ORF086R is 7.87, its position on 2D 
gel will lie in the poorly separated alkaline region, and may not be detectable. 
Possible phosphorylation of ORF086R in the knockdown group will shift it to a lower 
pI, making its identification possible (the observed pI was 6.3). The spot 22 (Figure 
3.6B) was identified as the host protein, eIF3 subunit 12. The control showed the 
absence of this spot, but instead by revealing three faint spots in the same location. 
However, we failed to identify these spots, probably because of low amounts.   
 
 Most interestingly, in the control group 4 clustered spots (spots 1-4, Figure 
3.6A) with increasing MW and decreasing pI were identified as ORF075R, indicating 
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that they may represent isoforms. This protein had been previously shown to be a 
major virus protein (Song et al., 2004; Song et al., 2006); within the ORF018R 
knockdown, it was represented by 5 clustered spots (spots 5-9, Figure 3.6B) with 
similar MW and pI trends. Tryptic digestion of these spots gave very similar Peptide 
Mass Fingerprints by MALDI-TOF MS (Figure 3.7). 2D Map comparison by 
PDQUEST indicated that the spot 5 (Figure 3.7) was a newly emerged spot in the 
ORF018R knockdown group (Figure 3.7). Analysis of this new spot by MALDI TOF-
TOF MS identified it as a variant of ORF075R. 
 
In the control group, 2D gels exhibited a large number of clusters of spots 
(area circled in dashed arc, Figure 3.6A). In the ORF018R knockdown, these same 
clusters were significantly altered by merging of multiple spots within each cluster 
and shifting towards lower pI (Figure 3.6). 
 
Because previous western blot analysis with the ORF018R knockdown had 
shown significantly enhanced phosphorylation of proteins in the region (Mr 17kDa-
32kDa), observed shifting of protein spots in the same region towards lower pI and 




























Figure 3.6 Detailed 2-DE maps of normal SGIV-infected cells (A) and ORF018R 
knockdown SGIV-infected cells (B).  
The identified spots were numbered as indicated in the 2DE maps and the 
identifications of the numbered spots were listed in Table 1. Arrows indicated the 
spots which located in the same area with spot22 in ORF018R knockdown group. 
Newly emerged spots (white circles); Knockdowned ORF018R (black circle); 




Table 3.1 Significantly altered proteins from SGIV-infected cells identified by 2-DE 
coupled with mass spectrometry 
 
Spot 





















protein score  
1a 5 362 270 47 38 
2a 5 272 192 46 38 
3a 7 387 295 46 49 
4a 5 234 168 38 38 
5 6 372 286 40 74 
1b 6 489 360 60 62 
2b 6 461 342 40 52 
3b 5 284 191 40 52 
4b 
ORF075R 
[SGIV] gi|56692712 19949 4.5 
3 234 139 40 55 
6a 7 586 465 63 50 
6b 5 489 413 66 58 
7 5 645 571 56 301 
8 
dUTPase 
[SGIV] gi|56692686 17106 6.51 
5 639 533 61 65 
9a 3 150 130 20 N/Aa 
9b 3 159 131 20 N/Aa 







gi|63002583 22156 6.82 
5 424 344 56 N/Aa 
12a 5 269 177 40 71 
12b 
ORF156L 
[SGIV] gi|56692793 31218 5.6 3 116 53 31 54 
13 ORF018R [SGIV] gi|56692655 32703 6.01 7 504 401 50 64 
14 ORF086R [SGIV] gi|56692723 17162 7.88 3 221 148 51 61 
15 LOC550245 [Danio rerio] gi|62955135 25639 4.92 2 133 68 36 37
b 
 
athe first 50 hits belonged to peroxiredoxin family when the spectra were searched 
against the whole NCBI database using MASCOT 2.0. 
 








Figure 3.7 ORF075R isoform cluster changes between control (A-a) and ORF018R 
knockdown (A-b) on 2DE.  
This 2DE result was from another independent knockdown experiment, which 
confirmed that one more isoform of ORF075R emerged (spot 5) and lower MW, 
higher pI isoform (spot 4b) become less in knockdown sample compared with the 
control. Similar MALDI-TOF MS peptide mass fingerprinting spectra for Spot 5 and 
4b (B). MALDI-TOF-TOF MS/MS spectra for the peptide ILDFSILETAATR with the 
















































































































































































































































































Spot 5 Spot 4b 




3.3.7 Further Confirmation of the Enhanced Phosphorylated Proteins with 
Linear Ion Trap Orbitrap (Thermo) 
Totally four potential enhanced phosphorylated proteins (ORF075R, dUTPase, NKEF, 
ORF086R) were identified with ABI 4700 MALDI TOF/TOF. However, it is very 
difficult to capture and identify the phosphorylated peptide and amino acid with 
MALDI TOF/TOF due to the altered charge and property of phosphorylated peptides. 
In order to identify the potential phosphorylated peptides, the samples were analyzed 
with a Linear Ion Trap Orbitrap (Thermo). The spectrums of dUTPase (142-152) were 
identified from all four spots (Figure 3.8B). For spot 10 and spot 11, no modification 
was found; for spot 12 one phosphoserine was identified and for spot 13 two 
phosphoserines were identified (Figure 3.8C). This result further proved that spot 12 
and spot 13 represented the enhanced phosphorylated isoforms of dUTPase which 
was in accord with previous Western Blot and 2D results (Figure 3.5&Figure 3.6). 
Thus knockdown of ORF018R did cause enhanced phosphorylation in SGIV-infected 



































































Spot 6a-Identified Spectrum: 
MS/MS Fragmentation of GSAGFGSTGVR 












Monoisotopic mass of neutral peptide Mr (calc): 994.48 
Fixed modifications: Carbamidomethyl (C) 
Ions Score: 78  Expect: 2.4e-008   










Spot 6b-Identified Spectrum: 
 
MS/MS Fragmentation of GSAGFGSTGVR 




Monoisotopic mass of neutral peptide Mr(calc): 994.48 
Fixed modifications: Carbamidomethyl (C) 
Ions Score: 82  Expect: 9.7e-009   











Spot 7-Identified Spectrum: 
MS/MS Fragmentation of GSAGFGSTGVR 









Monoisotopic mass of neutral peptide Mr (calc): 1074.4496 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: 
S7 : Phospho (ST), with neutral losses 0.0000(shown in table), 97.9769 
Ions Score: 48 Expect: 1.5e-005 









Spot 8-Identified Spectrum: 
MS/MS Fragmentation of GSAGFGSTGVR 









Monoisotopic mass of neutral peptide Mr (calc): 1154.4159 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: 
S2 : Phospho (ST), with neutral losses 0.0000(shown in table), 97.9769 
S7 : Phospho (ST), with neutral losses 0.0000(shown in table), 97.9769 
Ions Score: 57 Expect: 1.2e-006 
Matches (Bold Red): 24/238 fragment ions using 47 most intense peaks 
 
Figure 3.8 Identification of phosphorylated peptide with LTQ-Orbit trap.  
The interesting area was amplified from control group (A-a) and ORF018R 
knockdown group (A-b). The identified peptide (underline) and the phosphorylated 




3.3.8 In Vitro Rescue Experiment with Recombinant ORF018R  
To further justify ORF018R function, the ORF018R knockdown sample was 
lysed by frozen/thaw method and purified recombinant ORF018R was added into cell 
lysates. The results showed that major changed spots from rORF018R added group 
(Figure 3.9C) and calf intestinal alkaline phosphatase (Figure 3.9D) were quite similar, 
in which many spots at low pI region were shifted to high pI region. This suggested 
that rORF018R itself could cause dephosphorylation in SGIV-infected cell lysates and 
rORF018R was a functional recombinant protein. Thus ORF018R was probably a 
novel phosphatase or a kinase inhibitor. However, In vitro experiment showed that 
purified rORF018R had no pNPP (p-Nitrophenyl Phosphate) hydrolase activity, which 
suggested that ORF018R was not a traditional phosphatase (Data not shown). Thus 


















        
       Figure 3.9 In vitro rescue experiments with recombinant ORF018R 
Purity of recombinant ORF018R (A). The ORF018R-knockdown sample was 
collected and lysed with frozen-thaw. The cell lysates concentration was determined 
and divided into three parts (300µg per se). Each part was incubated with ORF018R 
storage buffer (B), 3.2 µg recombinant ORF018R (C) and 1unit calf intestinal alkaline 
phosphatase (CIAP) (Promega) (D) and loaded for 2DE gel. Purified recombinant 

































3.3.9 Protein Characteristics of rORF018R   
 Previous in vitro rescue experiment suggested that rORF018R folded correctly 
and had similar function with native ORF018R. Thus we performed some in vitro 
analyses of ORF018R with the aim to further understand its function. The optimized 
storage buffer was 10mM Hepes pH8.0, 100mM NaCl, 1mM DTT in which the 
protein was stable at 16mg/ml and remained homogenous (Figure 3.10).  
For the expression of ORF018R, we have changed E.coli strain from BL21 
(DE3) star to Origami B. The solubility of ORF018R was greatly increased with 
expression in Origami B, this suggested that the proper disulfide bond formation was 
probably important for ORF018R folding (Origami B has mutations in both the 
thioredoxin reductase and glutathione reductase genes and greatly enhances disulfide 
bond formation in the cytoplasm). Moreover, ORF018R was sensitive to many 
bivalent metal ions such as Zn2+, Mn2+ Ni2+, Cu2+and Fe3+ (Figure 3.11), this 





























Figure 3.10 DLS result of rORF018R 
 
The left window showed that ORF018R behaves as a 146kDa protein with 16mg/ml 
in 10mM HEPES pH8.0, 100mM NaCl, 1mM DTT at 4°C, possibily undergoing 
equilibrium between the tetramer (128kDa) and pentamer (160kDa). The right 



























Figure 3.11 CD profile of rORF018R upon metal ion changes. 
A. rORF018R was incubated with 0.1mM MgCl2, 1mM MgCl2, and 10mM MgCl2 
separately for 5 min at R.T., and subjected to measurement. B. rORF018R was 
incubated with 100mM MnCl2, 100mM NiSO4, 100mM CaCl2, and 100mM KCl 
separately for 5 min at R. T., and subjected to measurement. The final concentration 















































































































3.3.10 In Vitro Phosphorylation by the Endogenous Protein Kinase 
When the in vitro reaction was carried out with previously described 
conditions (Aubertin et al., 1980), many virion proteins were heavily phosphorylated 
(Figure 3.12). This result agreed with the previous report (Aubertin et al., 1980), 
which suggested that similar kinases and substrates existed in FV3 and SGIV. Based 
on the previous proteomics and bioinformatics study, one major virion protein 
ORF039L contained conserved serine/threonine kinase domain and was conserved in 
all sequenced iridovirus genome (Song et al., 2006; Eaton et al., 2007). Thus 
ORF039L was probably the endogenous kinase which could hyperphosphorylate 
virion proteins in vitro. In order to justify this hypothesis, we purified the C-terminal 
truncation of ORF039L (558-1051) and ORF075R from E.coli and found that purified 
ORF039L could phosphorylated ORF075R with ATP and MgCl2  in vitro (Figure 
3.13), which proved that ORF039L was a real kinase and ORF075R was probably a 
real substrate for this kinase. Moreover, purified FV3 virion could dephosphorylate 
the hyperphosphorylated virion proteins in the presence of Mn2+ (Silberstein and 
August, 1973). Here we have found that SGIV virion also had similar negative 
regulations and with the addition of Mn2+ the enhanced phosphorylation was blocked 
(Figure 3.12). Thus SGIV virion was similar to FV3 and the phosphorylations were 























Figure 3.12 Electrophoretic separations of phosphorylated SGIV polypeptides in vitro.  
Purified SGIV (100µg proteins) was disrupted in 25mM Tris-HCl (pH 8.0) buffer, 
10mM DTT, 0.5% NP40 at 30°C for 30 min, and proteins were phosphorylated by 
addition of (1) Buffer only (2) 0.2mM ATP, 10mM MgCl2 or (3) 0.2mM ATP 10mM 
MgCl2 1mM MnCL2 in 200 µl final vol and incubation at 30°C for 15 min. The 
reaction was stopped by addition of 5*SDS loading dye (250mM Tris-HCl pH 7.0, 
50% glycerol, 0.5% Bromophenol Blue, 20% SDS, 200mM DTT). For each lane 
certain treated virions (30µg proteins) were loaded on 12% acrylamide gel and stained 
with (A) ProQ DiamondTM (Invitrogen) and (B) silver staining (Chapter II) in 






























Figure 3.13 In vitro viral encoded kinases assays.  
(A) Purified ORF039L (558-1051).  
(B) Detection of phosphoproteins with ProQ diamond staining.  
(C) Detection of proteins with Coomassie Blue staining. 
 
Purified rORF075R (1µg) was phosphorylated by addition of (1) 1mM ATP, 10mM 
MgCl2 (2) 1mM ATP, 10mM MgCl2, 1µg purified rORF018R (3) 1mM ATP, 10mM 
MgCl2, 1µg purified rORF039R (558-1051) in 10 µl final vol. The reaction mixtures 
were incubated at 25°C for 10 min and the reaction was stopped by addition of 5*SDS 
loading dye (250mM Tris-HCl pH 7.0, 50% glycerol, 0.5% Bromophenol Blue, 20% 
SDS, 200mM DTT). The samples was loaded for SDS-PAGE and the gel was stained 
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3.4 Discussion 
ORF018R is a conserved iridovirus protein which is abundant in mature SGIV 
virion (Song et al., 2006; Eaton et al., 2007). Given this background, the present 
investigation has shown that the loss of ORF018R function resulted in enhanced 
phosphorylations, and numerous protein spots were noted to shift toward lower pI, 
higher molecular mass regions on the 2DE map. Twenty two spots were further 
identified that that belonged to six proteins by MS analyses. Our results demonstrated 
that the combination of loss of function analysis with the powerful proteomics 
technology is an effective way to explore the functional by viral essential genes and 
their regulatory mechanisms. This will be helpful in elucidating virus infection 
mechanism and accelerating antiviral drug discovery.    
 
Among the seven identified proteins, ORF075R is one of the most abundant 
virion proteins. Previous one dimensional SDS-PAGE has revealed that this protein is 
the second most abundant virion protein (Song et al., 2005; Song et al., 2006). Our 
2DE revealed that four isoforms of ORF075R exsisted in SGIV-infected cells, and an 
extra isoform with lower pI, higher molecular mass appeared with ORF018R 
knockdown. Consistent with observed enhanced phosphorylations revealed by 
phosphoserine antibody, ORF075R, which is located in the enhanced phosphorylation 
region in SDS-PAGE, was most likely further phosphorylated in ORF018R 
knockdown group, the enhanced phosphorylations of ORF075R may contribute to the 
viral genome packaging distortion.  
 
The subunit 12 of eIF3 is another interesting target, which is one of the largest 
initiation factors and it assembles on the 40S subunit to participate in the different 
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reactions involved in translation (Hinnebusch, 2006). EIF3 plays important roles in 
many viral proteins synthesis including herpesvirus (Fontaine-Rodriquez, 2004), 
hepatitis C virus (Fraser and Doudna, 2007), and Rabies virus (Komarova et al., 
2007). Phosphorylation of eIFs is regarded as a common translational control 
mechanism (Sarre, 1989). Here ORF018R knockdown resulted in decreased 
expression levels of viral proteins during later stages of viral infection. Thus 
ORF018R knockdown might affect viral late proteins synthesis by the modification of 
certain translation elongation factors.  
 
Both dUTPase and NKEF had two extra spots detected only in ORF018R 
knockdown group and the extra spots shifted toward the higher molecular mass and 
lower pI positions compared with the spots representing these two proteins in control 
group. These were well in accord with the observed enhanced serine phosphorylations 
and suggested these extra spots probably represent phosphorylated dUTPase and 
NKEF. Because the phosphorylated NKEF and dUTPase were only detected in 
ORF018R knockdown group, phosphorylation of these two proteins may not 
contribute to virus infection and it was probably caused by uncontrolled virus-
encoded protein kinases. Similarly ORF086R was a putative IE gene in SGIV and no 
obvious phenotypic changes were observed with the knockdown of its homologue in 
FV3 which suggested that this gene may not be an essential gene for SGIV infection 
(Sample et al., 2007; Willis et al., 1984). The spot representing ORF086R was only 
detected in ORF018R knockdown group and its pI revealed on 2DE map (about 6.3) 
was much less than ORF086R predicted pI (7.87), this suggested this spot probably 
represented phosphorylated ORF086R.   
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Thirty years ago more than a 15-fold increase in the specific activity of protein 
kinase was observed in FV-3 infected cells. A virus-specific serine/threonine kinase 
was identified in purified virion, which could phosphorylate many FV-3 virion 
proteins in vitro (Silberstein and August, 1973; Silberstein and August, 1976). This 
suggested that virus-encoded protein kinase probably played a central role in the 
protein phosphorylations of iridovirus-infected late stage cells. Recently nine 
sequenced iridovirus genomes have been compared by bioinformatics analyses and 
two serine/threonine protein kinases were conserved in all these iridoviruses (Eaton et 
al., 2007). SGIV ORF039L, one of the conserved serine/threonine protein kinases in 
iridovirus family, has been identified as an abundant virion protein by our previously 
proteomics study (Song et al., 2004; Song et al., 2006). Both SGIV ORF039L and its 
homolog FV3 ORF019R contain virus-specific 2-cysteine adaptor domains followed 
by a Ser/Thr protein kinase catalytic domain. They should function as Ser/Thr protein 
kinases to phosphorylate virion proteins in mature iridovirus virions. The in vitro 
study indicated that the purified recombinant truncated ORF039L containing the 
Ser/Thr protein kinase domain was able to phosphorylate the recombinant ORF075R 
(Figure 3.12). In SGIV-infected cells, ORF075R was phosphorylated. In addition, loss 
of ORF018R function further enhanced phosphorylations of ORF075R, and led to 
virion particle assembly distortion. Moreover, in vitro experiment showed that the 
purified recombinant ORF018R had no pNPP (p-Nitrophenyl Phosphate) hydrolase 
activity (data not shown), suggesting that ORF018R was not a traditional phosphatase. 
Therefore, we postulate that ORF018R functions as a negative regulator of Ser/Thr 
phosphorylation of some proteins. It participates in the regulation of protein Ser/Thr 
phosphorylation and may coordinate with virus-encoded Ser/Thr protein kinases such 
as ORF039L to maintain the phosphorylation/dephosphorylation homeostasis of the 
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viral phospho-protein targets such as ORF075R for viral protein synthesis and viral 
genome packaging. Because ORF018R, ORF039L and ORF075R are known to be 
three abundant proteins in SGIV mature virions (Song et al., 2004; Song et al., 2006) 
and both ORF018R and ORF039L are conserved in vertebrate iridoviruses (Eaton et 
al., 2007), this phosphorylation/dephosphorylation regulation probably represents a 
general phenomenon in vertebrate iridovirus but its detailed mechanism remains to be 
further studied.    
 
3.5 Implications 
Protein phosphorylation plays an important role in the life cycle of many 
viruses. Many enveloped animal viruses encode their own serine/threonine kinases 
which phosphorylate not only viral proteins but also host proteins (Webb et al., 2006; 
Benetti and Roizman, 2004). Iridoviruses, like other animal viruses, also encode their 
own serine/threonine kinases, which have been found in recent bioinformatics 
analyses (Eaton et al., 2007). The proteomics studies have confirmed that one 
predicted serine/threonine kinase-ORF039L was an abundant virion protein (Song et 
al., 2006). In this chapter, we found that serine/threonine phosphorylations were well 
controlled and important for iridovirus infection. Furthermore, we identified a 
potential substrate-ORF075R which might be important for viral genome packaging. 




































Iridovirus contains many unknown proteins (Eaton et al., 2007). In order to 
explore the function of these unknown proteins, we have adopted two general 
strategies: 1. to purified recombinant GST-fusion viral proteins from E.coli for pull 
down assay to screen for virus-host protein interaction; 2. to overexpress EGFP fusion 
viral proteins in the Grouper Embryonic Cells and check the localization of viral 
protein. In this chapter we have chosen ORF013R, ORF018R, ORF026R, ORF082L, 
ORF089L, ORF093L, ORF125R and ORF160L as targets. All these genes were late 
viral genes and the identity of these presumptive viral proteins was validated using 
three different proteomics methods (Chen et al., 2006) (Song et al., 2006). 
 
Table3.1 and Table3.2 show that ORF013R is a unique ORF which was identified 
only once by proteomics methods (1D SDS-PAGE MALDI TOF PMF approach); 
ORF018R, 026R, 089L were identified by all three methods and were conserved at 
least in other four iridovirus; ORF082L, 125R were identified by two methods and 
only conserved in GIV; ORF093L was identified by two methods and homology with 
other six ORFs in SGIV (1D SDS-PAGE MALDI-TOF MS/MS approach and 1D 
SDS-PAGE MALDI TOF PMF approach); ORF160L was only identified by 1D SDS-
PAGE MALDI TOF PMF approach and conserved in other eight iridovirus (Song et 








































ORF013R 140 14.49 No No No No No No No No 
ORF018R 285 32.32 Yes Yes Yes Yes No No No No 
ORF026R 566 63.32 Yes Yes Yes Yes Yes Yes No No 
ORF082L 222 24.32 No No No Yes No No No No 
ORF089L 390 45.59 Yes Yes Yes Yes No No No No 
ORF093L 405 47.59 Yes Yes Yes Yes No No No No 
ORF125R 184 21.08 No No No Yes No No No No 



























ORF013R Yes No No Unknown 
ORF018R Yes Yes Yes serine-threonine kinase 
ORF026R Yes Yes Yes AcetylCoA Hydrolase 
ORF082L Yes No Yes Unknown 
ORF089L Yes Yes Yes Unknown 
ORF093L Yes Yes No Unknown 
ORF125R Yes No Yes Unknown 












4.2 Materials and Methods 
4.2.1 Primers Design 
Primer design was based on the previously sequenced SGIV genome (Song et 
al., 2004).  
Primers for viral genes cloned into pGEX-6p-1: 
ORF082L:  5’-CGGAATTCATGAACCCTCCTAACG 
                     3’- CCCTCGAGTTAATAAAGACATTCTTC 
Primers for viral genes cloned into pEGFP-N1: 
ORF013R:  5’-CCAAGCTTATGGCTGTGGGTTTTATCGAC 
                    3’-AACTGCAGTAGCCCTTCACCCGTGGCGC 
ORF018R:  5’-CCCAAGCTTATGTCCGTAAAACTATCTGA 
                     3’- AACTGCAGTTAATTTTGAGCTGTTCTGG 
ORF026R:   5’-CCCAAGCTTATGGCAACTATACAAATGTCAAAA 
                      3’- AACTGCAGGGCTTCGGAAAGGATACCTT 
ORF082L:   5’- CCGCTCGAGATGAACCCTCCTAACGCAGC 
                     3’-CCCAAGCTTTTAATAAAGACATTCTTCGT (FULL LENGTH) 
                      3’- CCCAAGCTTTAAAGAAAGCGCCATGCGTCT (1-140) 
                      5’ - CCGCTCGAGATGATGGAGCACATACAGAGGTTA (96-222) 
                   5’ – CCGCTCGAGATGCCCAGGAGCCACGTACCCGGG (141-222) 
ORF089L:    5’- CCCAAGCTTATGGCAGATTGGCTAGTATCCC 
                       3’- AACTGCAGTTAATCCATCCTGCGCCTGC 
ORF093L:    5’-CCCAAGCTTATGGACTATTCGTCTGCTTACAA 
                       3’- AACTGCAGTCAAATTTGGTCGTCGTTTG 
ORF125R:    5’- CCGCTCGAGATGTTTGTGGTTGTAGCTCTAGTTTT 
                       3’- CCCAAGCTTCACGCTGACATCTATGTCGTTAA 
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ORF160L:    5’- CCCAAGCTTATGATTACCCAAATAGTAAAATATTT 
                       3’- AACTGCAGAATGATTACGTACGCGTCGTGA 
 
4.2.2 Purification of Recombinant Viral Proteins and Antibodies Preparation 
ORF082L was cloned into pGEX-6p-1. The recombinant GST fusion protein 
was purified with glutathione-Sepharose 4B beads (Pharmacia). The GST-ORF082L 
was eluted from beads with 10mM Reduced Gluotathione (Bio Basic). The eluted 
GST-ORF082L was passed through a SuperdexTM 75 column (Pharmacia). GST was 
purified as described above. The purified GST-ORF082L mixed with Freund’s 
adjuvant was injected into mouse to produce the mouse anti-ORF082L polyclonal 
serum. Polyclonal antibody (MAb) to actin was from Sigma. Anti-rabbit 
AlexaFluor594-conjugated antibody and anti-mouse Alexafluor488-conjugated 
antibody were used as the secondary antibody (Invitrogen) 
 
4.2.3 Delivery of pEGFP Vectors 
The vectors were purified with QIAfilter Plasmid Midi KitTM. For each 
transfection, 2µg vector was incubated with 670µl Eagle minimum essential medium 
(MEM) at R. T. for 5min, and then 30µl lipofectamine 2000 (Invitrogen) was 
incubated with 720µl MEM at R. T. for 5min, finally these two mixtures were 
incubated together for another 20 min at R. T.  The monolayer cells grown on 6 well 
plates were washed with PBS for 2 times. The medium containing lipofectamine 2000 
and vector was applied to cover the monolayer cells for 2h and then the fresh medium 
containing 10% FBS was added into the well. After 24 hours the cells were observed 
by an Olympus FluoViewTM  500 confocal microscopy. Images were processed with 
Adobe PhotoShop version 7.0.  
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4.2.4 Immunofluorescence (IF) Analyses for ORF082L  
Grouper embryonic cells were grown to near confluence on Lab-Tek® 
Chambered Coverglass (Nalge Nunc) infected with SGIV with an MOI (multiplicity 
of infection) of 5. Cells were fixed at 0, 6, 24 h p.i. separately with 3% 
paraformaldehyde, permeabilized with 100% methanol, and then incubated with 
mouse polyclonal antisera prepared against ORF082L (1:200) and rabbit polyclonal 
antibody against actin from Sigma (1:200). Anti-rabbit AlexaFluor594-conjugated 
antibody and anti-mouse Alexafluor488-conjugated antibody were used as the 
secondary antibody (Invitrogen). DsDNA were stained with Hoechst (Invitrogen). 
Fluorescence was detected with an Olympus FluoViewTM  500 confocal microscopy. 
Images were processed with Adobe PhotoShop version 7.0.  
 
4.2.5 GST Pull Down Assay and Mass Spectrometry Analyses for ORF082L 
The uninfected grouper embryonic cells were collected, lysed in lysis buffer 
[50mM Tris pH 8.0, 150mM NaCl, 1% NP-40, 2 mM sodium vanadate and protease 
inhibitor cocktail (Roche)], and centrifuged for 10min at 12000g. The supernatant was 
incubated with purified GST-ORF082L for 1h at R. T. and the Sepharose 4B beads 
(Amersham) was added and incubated for another 10 min. The beads were cleaned 
with wash buffer (50mM Tris pH 8.0, 150mM NaCl, 1% NP-40) for 200 bed volume 
and then boiled with SDS-loading dye for SDS-PAGE analyses.  
 
The SDS-PAGE was coomassie blue stained and the bands of interest were 
excised and digested with the sequencing grade modified porcine trypsin (Promega) 
as described previously (Huang et al., 2002). MS and MS/MS spectra were obtained 
using the ABI 4700 Proteomics Analyzer MALDI-TOF/TOF mass spectrometer 
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(Applied Biosystems). The MS, together with MS/MS, spectra were searched against 
the whole NCBI database using MASCOT 2.0 (Matrix Science). 
 
4.3 Results 
4.3.1 Overexpression of EGFP Fusion Proteins in GE Cells 
Vectors pEGFP-N1 cloned with different SGIV ORFs were delivered. Living 
cells were observed with an Olympus confocal microscopy. The results shown in 
Figure 5.1 indicated that ORF013R, ORF018R, ORF026R, ORF089L, ORF093L, 
ORF125R and ORF160L did not show any obvious preferential localization in the 
host cells compared to EGFP expression; ORF082L had a special localization in GE 







































Figure 4.1 Overexpression of EGFP fusion viral proteins in GE cells    
 
Vectors were delivered with Genejuice transfection reagent and the single cell was 




pEGFP-N1 pEGFP-N1_13 pEGFP-N1_18 
pEGFP-N1_26 pEGFP-N1_82 pEGFP-N1_89 
pEGFP-N1_93 pEGFP-N1_125 pEGFP-N1_160 
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4.3.2 Localization Study of ORF082L  
To further determine the localization of ORF082L, ORF082L-EGFP was 
delivered to HCT116-a human colon cancer cell and it showed similar preferential 
localization in HCT116 as compared with GE cells (Figure 4.2B). This could be 
caused by two reasons: 1. ORF082L could assemble by itself as certain particles. 2. 
ORF082L probably interacted with highly conserved host proteins and form special 
complexes. Since ORF082L has been detected in purified SGIV virion as a low 
abundant viral protein (Song et al., 2004; Preston and McDougall, 2002), it is more 
likely that the protein is involved in interaction between virion and host cell rather 
than its self assembly.  
 
To screen which part of this protein makes a major contribution to the special 
localization, ORF082L (1-140)-EGFP, ORF082L (96-222)-EGFP and ORF082 (141-
222)-EGFP were overexpressed in GE cells separately. Our results indicated that 
ORF082L (1-140) mainly contributed to its localization and the lack of the first 95 
amino acids would cause the complete loss of its localization in GE cells (Figure 
4.2C). Protein sequence analysis showed that ORF082L (165-169) was a proline rich 
region (4 Pro in 5 amino acids) and further secondary structure prediction revealed 
that the C-terminal of ORF082L was mainly composed of random coils. Thus further 


























Figure 4.2 Localizations of ORF082L-EGFP fusion proteins  
Vectors were delivered with Genejuice transfection reagent and the single cell was 
captured at 24 h posttransfection for each pEGFP fusion construct.   
A-1, EGFP control in GE cells; A-2 ORF082L-EGFP in GE cells;  
B-1, EGFP control in HCT116 cells; B-2, ORF082L-EGFP in HCT116 cells;  
C-1, ORF082L (1-140)-EGFP in GE cells; C-2, ORF082L (96-222)-EGFP in GE cells; 





C-1 C-2 C-3 
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4.3.3 ORF082L Pull Down Assay 
To further explore binding partners of ORF082L in host cells, we performed 
GST pull down assay. Previous secondary structure prediction has suggested that 
ORF082L contained a random coiled C-terminal which might be easily degraded. 
This was validated by the fact that GST-ORF082L was degraded during incubation 
with uninfected cell lysates (Figure 4.3-Lane G). In order to remove the non-specific 
binding with Sepharose 4B beads and GST, intensive wash was applied. Lane F 
showed that the control sample (Sepharose 4B beads with GST) did not bind with the 
proteins in uninfected cell lysates, which suggested the wash was effective and the 
non-specific binding had been completely removed.  
 
The bands on lane G were excised and sent for MS identification. The results 
were listed in Table 4.3. The results showed that GST-ORF082L was partially 
degraded (Figure 4.4) and the C-terminal of ORF082L was not identified for band 4, 
this suggested that the C-terminal of ORF082L was degraded in uninfected cell 
lysates as expected. Moreover, two host proteins, actin and enolase, were identified as 
potential binding partners of ORF082L. Actin was one of the major components of 
cytoskeleton and its assembly was complex in cytoplasm. Thus binding with actin was 












                  
 
Figure 4.3 GST pull down assay with uninfected GE cell lysates   
 
 
12% SDS-PAGE was run at R.T. Sample A was protein marker; Sample B 
(Glutathione beads), C (20 µg Purified GST on glutathione beads) and D (5µg 
Purified GST-ORF082L on glutathione beads) were mixed with 5ΧSDS loading dye 
and boiled; For sample E, F and G, the same amount of glutathione beads, purified 
GST on glutathione beads and purified GST-ORF082L on glutathione beads were 
incubated with uninfected GE cell lystates (200µg for each sample) for 1 hour at R. T. 
and washed with wash buffer (20mM Tris-HCL  pH 7.5, 100mM NaCl, 0.5% NP40) 
for three times and then handled for SDS-PAGE. The labeled bands were excised and 





















































[SGIV] gi¦56692719 24423 9.02 459 62 
2 
Enolase 1 




mykiss] gi¦8886013 42012 5.38 494 49 
4 
ORF082L 



























A. Band 1 
B. Band 2 
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4.3.4 Time Course of ORF082L Localization Study in SGIV-infected GE Cells 
To further explore the localization of ORF082L in different SGIV infection 
stage, the cells infected with SGIV (MOI=3) were fixed at 0h, 6h and 24h and 
immuno-stained (Figure 4.5). DNA was localized in cell nuclear at the early infection 
stage (Figure 4.5A) and viromatrix filled with viral genomic DNA was formed in the 
cytoplasm at the late infection stage (Figure 4.5A). This was in accord with previous 
observations, in which the majority of viral DNA synthesized in the cytoplasm at the 
late infection stage and viral genome was packaged at viroplasm (Goorha, 1982; 
Huang et al., 2006). Actin existed as bundles of microfilaments at the beginning of 
infection (Figure 4.5B), at 6 hours postinfection the actin subunits began to disperse 
and at 24 hours postinfection the actin subunits dispersed and rearranged. This was 
consistent with previous FV3 studies (Murti and Goorha, 1983). Moreover, we found 
that actin formed special bundles in the cell nucleus at 24 hours postinfection which 
might be involved in viral protein and DNA transportation. ORF082L was one of the 
identified virion proteins (Song et al., 2004). Here we found that this protein had 
different localizations at different viral infection stages. This protein was mainly 
localized in the cell nucleus at 6 hours postinfection and re-localized in the cytoplasm 
at 24 hours postinfection. Because this protein was one of virion proteins (Song et al., 

























Figure 4.5 Time course of ORF082L localization in SGIV-infected GE cells 
The monolayer cells were infected with SGIV (MOI=3) and fixed at 0 h, 6 h and 24 h 
postinfection. The fixed monolayers were processed for IF assay using the indicated 
combination of primary antibodies (α) and Alexa-488-conjugated secondary 
antibodies (green) and Alexa-594-conjugated secondary antibodies (red). DsDNA 









A. DsDNA staining          B. α-actin                  C. α-ORF082L                D. Merge 
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4.4 Discussion 
4.4.1 Bioinformatics Analyses of ORF082L and Its Potential Function 
We further clarify ORF082L’s function with PFP (protein function prediction) 
(http://dragon.bio.purdue.edu/pfp). This enhanced automated function prediction was 
based on distantly related sequences and contextual association analysis (Hawkins et 
al., 2006).  
 Based on the prediction, ORF082L probably functions as a DNA 
methyltransferase. In the nine sequenced iridovirus genomes, only SGIV and 
Invertebrate iridescent virus 6 (IIV-6) do not have any DNA methyltransferase based 
on bioinformatics. Normally viruses encode DNA methyltransferase for the 
methylation of their own genomes and this methylation is considered to protect viral 
genome from host DNase and virus gene transcription regulation (Doerfler, 2005). At 
the early infection stage of iridovirus, viral genome needs to enter the cell nucleus to 
initiate its replication and transcription. Thus methylation of viral genome is probably 
considered as an important protective mechanism for iridovirus. Previous study on 
frog virus 3 also showed that the actively transcribed genome of frog virus 3 (FV3) is 
completely 5’-CG-3’ methylated (Willis and Granoff, 1980). Thus the functional 
prediction of ORF082L is reasonable because protein primary sequence is much more 
easily changed than its structure and function. One of the reasons for the lack of DNA 







           Table 4.4 Function prediction of ORF082L with PFP 
 













GO.0005634      score: 241.74
definition: nucleus
 
GO.0015948      score: 69.35 
definition: methanogenesis 
GO.0018024      score: 200.67 
definition: histone-lysine N-
methyltransferase activity 
GO.0005721      score: 51.28 
definition: centric 
heterochromatin 
GO.0006342      score: 52.88 
definition: chromatin silencing 
 
GO.0016740      score: 152.67
definition: transferase activity
 
GO.0000786      score: 38.88
definition: nucleosome
 
GO.0009266      score: 46.76 
definition: response to 
temperature 
 




GO.0016020      score: 30.42 
definition: membrane
 
GO.0007179      score: 39.68 
definition: transforming 
growth factor beta receptor 
signaling pathway 
GO.0008270      score: 113.43  
definition: zinc ion binding
 
GO.0000794      score: 26.21
definition: condensed nuclear 
chromosome 
 
GO.0006355      score: 36.49 
definition: regulation of 
transcription, DNA-dependent 
GO.0005554      score: 64.93
definition: molecular_function 
unknown 
GO.0016021      score: 22.30
definition: integral to 
membrane 
GO.0051101      score: 34.12 
definition: regulation of DNA 
binding 
GO.0005524      score: 49.17
definition: ATP binding 
GO.0030424      score: 19.03
definition: axon 
GO.0009968      score: 29.33 
definition: negative regulation 
of signal transduction 
GO.0016251      score: 42.70
definition: general RNA 
polymerase II transcription 
factor activity 
GO.0005737      score: 15.37
definition: cytoplasm 
GO.0006356      score: 28.75 
definition: regulation of 
transcription from Pol I 
promoter 
GO.0016165      score: 42.64
definition: lipoxygenase 
activity 
GO.0005856      score: 14.33
definition: cytoskeleton 
GO.0007281      score: 27.72 
definition: germ cell 
development 
GO.0003677      score: 37.65
definition: DNA binding 







4.4.2. Some Indirect Evidence for ORF082L Function 
Bacteriophage T1, another DNA virus, encodes a DNA methyltransferase 
which interacts with Escherichia coli enolase (Gassner et al., 1998). ORF082L also 
interacts with enolase, which suggests that virus-encoded DNA methyltransferase 
interacting with host enolase might be a general phenomenon. Apart from its 
glycolytic function, enolase has also been shown to possess antigenic properties and 
to be present on the surface of certain cells (Pal-Bhowmick et al., 2007). Thus enolase 
might also contribute to ORF082L-EGFP localization.  
 
Time course immunofluorescence staining revealed that at the early infection 
stage, ORF082L was concentrated at cell nucleus and at the late infection stage 
ORF082L was localized at cytoplasm. This was in accord with the fact that 
iridoviruses begin their replication in the cell nucleus but the majority of its genome 
amplification happened in the viroplasm (Williams, 1996). ORF082L would serve its 
protective function at the viral genome duplication in the early-stage of SGIV 
infection. In the late-stage of infection, viral genome was replicated in the viroplasm 
where the environment was suitable for virion assembly and viral DNA might not 
need to be methylated. Localization of ORF082L in the mature virions might serve its 
protection in the next round of infection (Song et al., 2006). The in vitro activity assay 
has been performed with common methyl donor [S-(5’-Adenosyl)-L-methionine 
chloride)] and SGIV genome DNA. However, the treated DNA could still be digested 
with Hpa II and Msp I which suggested C and G were not methylated. This was 
probably caused by the poor stability and solubility of rORF082L.  
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 Furthermore, Table 4.5 shows the comparison between ORF082L and other 
iridovirus encoded DNA methyltransferase. High similarities in protein length, pI and 
MW also suggest that ORF082L is probably a DNA methyltransferase in SGIV.    
 
 
Table 4.5 The comparisons of MW and pI between ORF082L and other iridovirus 
encoded DNA methyltransferases 
 
Species pI MW (Da) aa 
Frog virus 3 9.02 24730 214 
Tiger frog virus 9.12 24812 214 
ATV 9.24 24780 214 
LCDV 9.5 26952 228 
ISKNV 9.36 25855 227 
SGIV ORF082L 9.02 24324 222 
 
4.5 Conclusion 
 Our results shows that DNA methyltransferase is probably not lost in SGIV 
during the evolution. Alternatively, this enzyme mutates so fast that blast can not 
identified it with sequence homolog. Whether ORF082L is a real DNA 
methyltransferase and what is the exact function during iridovirus infection remain to 






















































5.1 General Conclusion 
The purpose of this study is to explore the infection mechanism of iridovirus 
and to screen essential iridovirus-encoded genes for anti-iridovirus drug design. Virus-
encoded proteins were expressed in different virus infection stages (Immediately early 
stage, early stage, late stage). Our lab has identified 61 proteins contained in purified 
SGIV and many of them were conserved proteins in iridovirus family with unknown 
function (Song et al., 2006). In this thesis we developed an effective way to screen the 
potential therapeutic targets for iridovirus-related disease. One important viral gene 
was found and its potential mechanism was explored. Our results showed that these 
methods were effective for early stage anti-iridovirus drug early-stage screen and they 
might be applied in other anti-virus drug design.  
 
 In detail, we have found that serine/threonine phosphorylation is critical for 
virus assembly and viral protein synthesis. It is well controlled by virus-encoded 
proteins. ORF018R and ORF039L are two candidates participated in this process and 
ORF075R is important in SGIV virion assembly and its phosphorylated isoforms 










5.2 Future Studies 
5.2.1 Screening More Essential Genes for Anti-Iridovirus Drug Design 
 One of the problems for screening viral essential genes is gene redundancies. 
In SGIV genome, ORF140R and ORF141R are homologs; ORF004L, ORF089L, 
ORF090L, ORF092L, ORF093L and ORF147L are homologs. This is probably the 
reason why knockdown of ORF093L and ORF140R did not cause any obvious 
phenotypic changes. These gene redundancies are probably caused by gene 
duplication in virus evolution history which makes knockdown study more complex. 
 
 On the other hand, successful antiviral drugs normally block virus infection in 
certain viral infection stage and many of them are targeted to certain virus-encoded 
enzymes, such as HIV protease inhibitor. Thus future screening should focus on 
selective virus-encoded enzyme, such as ORF039L, ORF150L and ORF078L. 
Inhibitors for such SGIV-encoded enzymes might be potential effective anti-iridovirus 
drugs. 
 
5.2.2 Explanation of how ORF018R acts in SGIV-infected late stage cells 
ORF039L has been identified as a SGIV-encoded kinase in the previous study. In 
order to verify whether ORF018R is a regulator of ORF039L, one possible solution is 
proposed as follows:   
 
Figure 5.1 A proposed method to verify ORF018R function 
 
Future studies can focus on the regulation role of ORF018R and its interaction with 
rdUTPase   +    rORF039L 
(with ATP, Mg2+  etc) 
Check dUTPase  
phosphorylated status  
with MS.  
+   rORF018R 
+        buffer 
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ORF039R.  Other kinases that will be regulated by ORF018R will also be examined 
in order to get the full picture of its function. 
 
5.2.3 Structure Studies for Viral Essential Enzymes       
Sequence based antisense oligos are excellent tools for functional study but 
may not be good drug candidates. One of the reasons is that virus mutates so fast that 
asMO knockdown effect is probably counteracted in a few generations with selection 
pressure. Compared with protein primary sequence based drug design, conserved 
functional domains for some essential viral enzymes are less likely to be changed. 
Iridovirus contain two highly conserved serine/threonine kinases and our results have 
shown that those kinases were probably functionally important during virus infection. 
Structural determination of such enzymes may be important for anti-iridovirus drug 
design.  
 
5.2.4 Functional Studies of ORF075R      
One abundant virion protein-ORF075R was subtly phosphorylated in SGIV-
infected late stage cells. It had four isoforms in normal infected cells and had five 
isoforms in ORF018R knockdown infected cells. At the same time, SGIV virion 
assembly was distorted. Additional information from LTQ-Orbitrap suggested that the 
three threonines located in the N-terminal acidic region of ORF075R were probably 
the phosphoryaltion regulated sites. Thus, we have purchased the casein kinase II for 
test for further studies. Recently, our lab has found that ORF075R interacted with 
certain lipid group. When ORF075R was phosphorylated by casein kinase II, the 
binding affinity to certain lipid group has been changed. This may suggest that the 
studies of ORF075R will shed light on how SGIV genome is packaged.  
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